51Թapp
Back to
Professor Sean Emery

Professor Sean Emery

Deputy Director
Medicine & Health
Faculty Office

Research Interests:
The evaluation of new treatments, new treatment strategies and biomedical preventive measures for HIV infection. The design and implementation of clinical research programs and projects to generate quality evidence to advise healthcare providers and policy makers. To balance high tech medicine with the reality of limited resources in countries where needs are greatest.

Broad Research Areas:
Clinical Research, HIV - AIDS, Immunology, Virology, Biostatistics

Qualifications:
BSc, PhD Brunel

Society Memberships & Professional Activities:
International AIDS Society (IAS), , Association of Regulatory and Clinical Scientists to the Australian Pharmaceutical Industry (ARCS)

Specific Research Keywords:
Acquired Immune Deficiency Syndrome (AIDS), Anti-viral Immunity, Biostatistics, Blood borne viruses, Clinical Research
Phone
93854229
E-mail
s.emery@unsw.edu.au
  • Book Chapters | 2013
    Emery S, 2013, 'Lipid Peroxidation, Antioxidants and Regenerating Rat Liver', in Nigram SK (ed.), Eicosanoids, Lipid Peroxidation and Cancer, Springer Science & Business Media, pp. 195 - 202
    Book Chapters | 2006
    Pett SL; Emery S; Cooper DA, 2006, 'Initial treatment of HIV-1 infection. Online access: www.antimicrobe.org', in Singh N; Swindells S; Shafer R (ed.), HIV Clinical Manual, edn. Original, ESun Technologies, LLC, online
    Book Chapters | 2005
    Ramacciotti TP; Smith DE; Emery S; Kelleher AD; Cooper DA, 2005, 'Therapeutic vaccination in PHI', in Jenssen H; Jager H (ed.), Primary HIV Infection ? Pathology, Diagnosis, Management, edn. Original, Thieme, Stuttgart, pp. 48 - 63
  • Journal articles | 2024
    Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Templeton DJ; Zablotska-Manos I; Hoy J; Bloch M; Baker D; Brown G; Grulich A; Bavinton B; Pinto AN; Orth D; Roth N; Moore R; Tee BK; Pell C; McNulty A; Templeton DJ; Doong N; Triffitt K; Koelsch KK; Wilson D; Fairley CK; Emery S; Kelleher A; Cooper DA; Grinsztejn B; Bavinton BR; Prestage GP; Zablotska IB; Grulich AE, 2024, 'Condom Failure Among HIV-Negative Men in Serodiscordant Relationships in Australia, Brazil, and Thailand', AIDS and Behavior, 28, pp. 3587 - 3595,
    Journal articles | 2024
    Matthews G; Jacoby S; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Bennet JA; Avihingsanon A; Chetchotisakd P; Wagner Cardoso S; Azwa I; Losso M; Brown D; Arlinda D; Hutchinson J; Kelleher A; Cisse M; Dao S; Polizzotto M; Emery S; Law M; Papot E; Karyana M; Lupo S; Solari AM; Grinsztejn B; Wolff M; Andrade-Villanueva J; Mosqueda Gómez JL; Chow TS; Mohapi L; Yunihastuti E; Hadi U; Katu S; Subronto YW; Lane HC; Perelis L, 2024, 'Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial', The Lancet HIV, 11, pp. e436 - e448,
    Journal articles | 2023
    Lundgren JD; Babiker AG; Sharma S; Grund B; Phillips AN; Matthews G; Kan VL; Aagaard B; Abo I; Alston B; Arenas-Pinto A; Avihingsanon A; Badal-Faesen S; Brites C; Carey C; Casseb J; Clarke A; Collins S; Corbelli GM; Dao S; Denning ET; Emery S; Eriobu N; Florence E; Furrer H; Fätkenheuer G; Gerstoft J; Gisslén M; Goodall K; Henry K; Horban A; Hoy J; Hudson F; Azwa RISR; Kedem E; Kelleher A; Kityo C; Klingman K; Rosa AL; Leturque N; Lifson AR; Losso M; Lutaakome J; Madero JS; Mallon P; Mansinho K; Filali KME; Molina J-M; Murray DD; Nagalingeswaran K; Nozza S; Ormaasen V; Paredes R; Peireira LC; Pillay S; Polizzotto MN; Raben D; Rieger A; Sanchez A; Schechter M; Sedlacek D; Staub T; Touloumi G; Turner M; Madruga JV; Vjecha M; Wolff M; Wood R; Zilmer K; Lane HC; Neaton JD; INSIGHT Strategic Timing of AntiRetroviral Treatment (START) Study Group , 2023, 'Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.', NEJM Evid, 2,
    Journal articles | 2023
    MacDonald DM; Samorodnitsky S; Wendt CH; Baker JV; Collins G; Kruk M; Lock EF; Paredes R; Poongulali S; Weise DO; Winston A; Wood R; Kunisaki KM; Aagaard B; Jansson PO; Pearson MT; Babiker AG; Arenas-Pinto A; Atako NB; Dennis E; Forcat S; Hudson F; Jackson B; Maas D; Purvis C; Russell C; Emery S; Carey C; Clewett M; Jacoby S; Gordin F; Vjecha M; Sanchez A; Loria GR; Doldan ML; Moricz A; Tillmann K; Müller V; Touloumi G; Gioukari V; Anagnostou O; Herrero P; Lopez P; Avihingsanon A; Rerksirikul P; Loiza E; Mingrone V; Lupo S; Marconi F; Daniel D; Crinejo A; French M; Barba L; Rowling D; Warzywoda E; Bloch M; Agrawal S; Dwyer D; Taylor J; van Petersen L; Mertens L; De Wit S; Kabamba K; Wolff M; Allendes G; Ristola M; Debham O; Jessen H; Jessen A; Wiebecke S; Klinker H; Fätkenheuer G; Lehmann C; Knaevelsrud I; Rittweger M; Stöhr A; Olah K; Schaaf B; Hower M; Harrer T; Harrer E; Skoutelis A; Papastamopoulos V; Metallidis S; Tsachouridou O; Pujari S; Chitalikar A; Kumarasamy N; Beulah F; Shahar E; Kedem E; Turner D; Madero JS; Madrigal C; Filali MKE; Erradey I; Ekong E; Eriobu N; Valencia J; León M, 2023, 'Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV', Scientific Reports, 13,
    Journal articles | 2021
    Burnett DL; Jackson KJL; Langley DB; Aggrawal A; Stella AO; Johansen MD; Balachandran H; Lenthall H; Rouet R; Walker G; Saunders BM; Singh M; Li H; Henry JY; Jackson J; Stewart AG; Witthauer F; Spence MA; Hansbro NG; Jackson C; Schofield P; Milthorpe C; Martinello M; Schulz SR; Roth E; Kelleher A; Emery S; Britton WJ; Rawlinson WD; Karl R; Schäfer S; Winkler TH; Brink R; Bull RA; Hansbro PM; Jäck HM; Turville S; Christ D; Goodnow CC, 2021, 'Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability', Immunity, 54, pp. 2908 - 2921.e6,
    Journal articles | 2021
    Gray J; Prestage G; Jin F; Phanuphak N; Friedman RK; Fairley CK; Kelleher A; Templeton D; Zablotska-Manos IB; Hoy J; McNulty A; Pell C; Grulich A; Bavinton B; Grinsztejn B; Cooper DA; Emery S; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Tee BK; Moore R; Roth N; Orth D; Pinto AN, 2021, 'Characteristics of Agreements to have Condomless Anal Intercourse in the Presence of an Undetectable Viral Load Among HIV Serodiscordant Male Couples in Australia, Brazil and Thailand', AIDS and Behavior, 25, pp. 3944 - 3954,
    Journal articles | 2020
    Dwyer DE; Lynfield R; Losso MH; Davey RT; Cozzi-Lepri A; Wentworth D; Uyeki TM; Gordin F; Angus B; Qvist T; Emery S; Lundgren J; Neaton JD, 2020, 'Comparison of the outcomes of individuals with medically attended influenza a and b virus infections enrolled in 2 international cohort studies over a 6-year period: 2009-2015', Open Forum Infectious Diseases, 4,
    Journal articles | 2019
    Bavinton BR; Prestage GP; Jin F; Phanuphak N; Grinsztejn B; Fairley CK; Baker D; Hoy J; Templeton DJ; Tee BK; Kelleher A; Grulich AE; Zablotska-Manos I; Cooper D; Triffitt K; Bloch M; McNulty A; Pell C; Emery S, 2019, 'Strategies used by gay male HIV serodiscordant couples to reduce the risk of HIV transmission from anal intercourse in three countries', Journal of the International AIDS Society, 22, pp. e25277,
    Journal articles | 2019
    Boatman JA; Baker JV; Emery S; Furrer H; Mushatt DM; Sedláček D; Lundgren JD; Neaton JD, 2019, 'Risk Factors for Low CD4+ Count Recovery Despite Viral Suppression among Participants Initiating Antiretroviral Treatment with CD4+ Counts > 500 Cells/mm3: Findings from the Strategic Timing of AntiRetroviral Therapy (START) Trial', Journal of Acquired Immune Deficiency Syndromes, 81, pp. 10 - 17,
    Journal articles | 2019
    Borges Á; Neuhaus J; Sharma S; Neaton JD; Henry K; Anagnostou O; Staub T; Emery S; Lundgren JD, 2019, 'The Effect of Interrupted/Deferred Antiretroviral Therapy on Disease Risk: A SMART and START Combined Analysis', Journal of Infectious Diseases, 219, pp. 254 - 263,
    Journal articles | 2019
    Dharan NJ; Neuhaus J; Rockstroh JK; Peters L; Gordin F; Arenas-Pinto A; Emerson C; Marks K; Hidalgo J; Sarmento-Castro R; Stephan C; Kumarasamy N; Emery S; Matthews GV, 2019, 'Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial', Hepatology, 69, pp. 1135 - 1150,
    Journal articles | 2019
    Lampe FC; Rodger AJ; Burman W; Grulich A; Friedland G; Sadr WE; Neaton J; Corbelli GM; Emery S; Molina JM; Orkin C; Gatell J; Gerstoft J; Ruxrungtham K; Barbosa De Souza M; Phillips AN, 2019, 'Impact of early antiretroviral treatment on sexual behaviour: A randomised comparison', AIDS, 33, pp. 2337 - 2350,
    Journal articles | 2019
    Lampe FC; Rodger AJ; Burman W; Grulich A; Friedland G; Sadr WE; Neaton J; Corbelli GM; Emery S; Molina JM; Orkin C; Gatell J; Gerstoft J; Ruxrungtham K; Barbosa de Souza M; Phillips AN; INSIGHT START Study Group , 2019, 'Impact of early antiretroviral treatment on sexual behaviour: a randomised comparison.', AIDS, 33, pp. 2337 - 2350,
    Journal articles | 2019
    Polizzotto M; Van Bockel D; Law C; Roberts J; Buckland G; Just S; Comben S; Hillman R; Gilson R; Pett S; Poynten M; Law M; Kelleher A; Emery S, 2019, 'Clearance of HPV Anal Premalignant Lesions and Modulation of Systemic Immune Responses to HPV Oncogenes with Low Dose Pomalidomide', Annals of Oncology, 30, pp. xi35 - xi35,
    Journal articles | 2019
    Revell AD; Wang D; Perez-Elias M-J; Wood R; Tempelman H; Clotet B; Reiss P; van Sighem AI; Alvarez-Uria G; Nelson M; Montaner JSG; Lane HC; Larder BA; Harrigan R; de Wit TR; Hamers R; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Kaiser R; Schuelter E; Streinu-Cercel A; Bals M; Alvarez-Uria G; Perez-Elias M-J; de Oliveira T; Gatell J; Lazzari E; Gazzard B; Nelson M; Pozniak A; Mandalia S; Smith C; Ruiz L; Clotet B; Staszewski S; Torti C; Lane HC; Julia A; Metcalf ; Rehm CA; Perez-Elias M-J; Vella S; Dettorre G; Carr A; Norris R; Hesse K; Vlahakis E; Tempelman H; Barth R; Wood R; Morrow C; Cogill D; Hoffmann C; Ene L; Dragovic G; Diaz R; Sucupira C; Sued O; Cesar C; Sierra Madero J; Balakrishnan P; Saravanan S; Emery S; Cooper D; Torti C; Baxter J; Monno L; Gatell J; Clotet B; Picchio G; deBethune M-P; Emery S; Khabo P; Ledwaba L, 2019, 'Predicting Virological Response to HIV Treatment Over Time: A Tool for Settings With Different Definitions of Virological Response', JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 81, pp. 207 - 215,
    Journal articles | 2019
    Sereti I; Gulick RM; Krishnan S; Migueles SA; Palfreeman A; Touzeau-Römer V; Belloso WH; Emery S; Law MG; Han A, 2019, 'ART in HIV-Positive Persons with Low Pretreatment Viremia: Results from the START Trial', Journal of Acquired Immune Deficiency Syndromes, 81, pp. 456 - 462,
    Journal articles | 2019
    Sereti I; Gulick RM; Krishnan S; Migueles SA; Palfreeman A; Touzeau-Römer V; Belloso WH; Emery S; Law MG; INSIGHT START Study Group , 2019, 'ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.', J Acquir Immune Defic Syndr, 81, pp. 456 - 462,
    Journal articles | 2019
    Singkham N; Avihingsanon A; Thammajaruk N; Ruxrungtham K; Bunupuradah T; Kiertiburanakul S; Chetchotisakd P; Burger DM; Emery S; Punyawudho B, 2019, 'Influence of CYP3A5 and SLCO1B1 polymorphisms on atazanavir/r concentrations in Thai HIV-infected patients', Pharmacogenomics, 20, pp. 517 - 527,
    Journal articles | 2018
    Bavinton BR; Pinto AN; Phanuphak N; Grinsztejn B; Prestage GP; Zablotska-Manos IB; Jin F; Fairley CK; Moore RD; Roth N; Bloch M; Pell C; McNulty AM; Baker D; Hoy J; Tee BK; Templeton DJ; Cooper DA; Emery S; Kelleher A; Grulich AE; Bas A; Cooper DA; Wilson D; Koelsch KK; Triffitt K; Doong N; Baker D; Bloch M; Pell C; Hoy J; Orth D, 2018, 'Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study', The Lancet HIV, 5, pp. e438 - e447,
    Journal articles | 2018
    Brummel-Ziedins KE; Gissel M; Neuhaus J; Borges ÁH; Chadwick DR; Emery S; Neaton JD; Tracy RP; Baker JV, 2018, 'In silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virus', Research and Practice in Thrombosis and Haemostasis, 2, pp. 708 - 717,
    Journal articles | 2018
    Forsberg LK; Anyika M; You Z; Emery S; McMullen M; Dobrowsky RT; Blagg BSJ, 2018, 'Development of noviomimetics that modulate molecular chaperones and manifest neuroprotective effects', EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 143, pp. 1428 - 1435,
    Journal articles | 2018
    Kent SJ; Hough S; Kelleher AD; Law MG; Hutchinson J; Catalfarmo M; van Bockel D; Lane C; Baker JV; Emery S; Han A, 2018, 'Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial', The Lancet HIV, 5, pp. e553 - e559,
    Journal articles | 2018
    Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Alberto Arnaiz J; Cooper D; Rockstroh JK; Mallon P; Emery S; Fisher M; Rockstroh J; Stellbrink J; Merlin K; Yeung J; Fsadni B; Marks K; Suzuki K; Rismanto N; Salomon H; Rubio AE; Chibo D; Birch C; Swenson L; Chan D; Berg T; Obermeier M; Schuelter E; Aragon SS; Luebke N; Coughlan S; Dean J; Iwatani Y; Teran GR; Avila S; Sirivichayakul S; Naphassanant M; Ubolyam S; Kaye S; Land S; Walker S; Haubrich R; DeJesus E; Berthon-Jones N; Espinosa N; Courtney-Vega K; Absar N; Haskelberg H; Robson R; Donaldson A; Guelman D; Gambardella L; Valdovinos M; Arnaiz J; Beleta H; Ramos N; Targa M; Späth B; Boesecke C; Engelhardt A; Perry N; Beckthold B; Drummond F; Lefevre E; Corr S; Grant C; Lupo S; Peroni L; Sanchez M; De Paz Sierra M; Viloria G; Parlante A; Bissio E; Luchetti P; Confalonieri V; Warley E; Vieni I; Vilas C; Zarate A; Mayer G; Elliot J; Hagenauer M; Kelley M; Bloch M; Cooper D, 2018, 'Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study', HIV Medicine, 19, pp. 65 - 71,
    Journal articles | 2018
    Pett SL; Kunisaki KM; Wentworth D; Griffin TJ; Kalomenidis I; Nahra R; Sanchez RM; Hodgson SW; Ruxrungtham K; Dwyer D; Davey RT; Wendt CH; Lundgren J; Jansson P; Pearson M; Aagaard B; Hudson F; Bennet R; Pacciarini F; Angus B; Paton N; Collaco Moraes Y; Cooper D; Emery S; Courtney-Rogers D; Robson R; Gordin F; Sanchez A; Standridge B; Vjecha M; Moricz A; Delfino M; Belloso W; Losso M; Tillmann K; Touloumi G; Gioukari V; Anagnostou O; La Rosa A; Saenz MJ; Lopez P; Herrero P; Portas B; Kaewon P; Ubolyam S; Brekke K; Campbell M; Denning E; DuChene A; Engen N; George M; Harrison M; Neaton JD; Nelson R; Quan SF; Schultz T; Baxter J; Brown S; Hoover M; Beigel J; Dewar R; Gover E; McConnell R; Metcalf J; Natarajan V; Rehman T; Voell J; Dwyer DE; Kok J; Uyeki T; Munroe D; Paez A; Bertrand M; Temesgen Z; Rizza S; Wolfe C; Carbonneau J; Novak R; Schwarber M; Polenakovik H; Clark L; Patil N; Riska P; Omotosho J; Faber L; Markowitz N; Glesby M; Ham K; Parenti D; Simon G; Coburn P; Freiberg M; Koerbel G; Dharan N; Paez-Quinde M; Gunter J; Beilke M; Lu Z; Gunderson E; Baker J, 2018, 'Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study', Open Forum Infectious Diseases, 5, pp. ofx228,
    Journal articles | 2018
    Simonsen L; Higgs E; Taylor RJ; Wentworth D; Cozzi-Lepri A; Pett S; Dwyer DE; Davey R; Lynfield R; Losso M; Morales K; Glesby MJ; Weckx J; Carey D; Lane C; Lundgren J; Emery S, 2018, 'Using clinical research networks to assess severity of an emerging influenza pandemic', Clinical Infectious Diseases, 67, pp. 341 - 349,
    Journal articles | 2018
    Trevillyan JM; Wong G; Puls R; Petoumenos K; Emery S; Mellett NA; Mundra PA; Meikle PJ; Hoy JF, 2018, 'Changes in plasma lipidome following initiation of antiretroviral therapy', PLoS ONE, 13, pp. e0202944,
    Journal articles | 2018
    Vanderven HA; Wragg K; Ana-Sosa-Batiz F; Kristensen AB; Jegaskanda S; Wheatley AK; Wentworth D; Wines BD; Hogarth PM; Rockman S; Kent SJ; INSIGHT FLU005 Pilot Study Writing Group , 2018, 'Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.', J Infect Dis, 218, pp. 1383 - 1393,
    Journal articles | 2018
    Yao AH; Moore CL; Lim PL; Molina JM; Madero JS; Kerr S; Mallon PWG; Emery S; Cooper DA; Boyd MA, 2018, 'Metabolic profiles of individuals switched to second-line antiretroviral therapy after failing standard first-line therapy for treatment of HIV-1 infection in a randomized, controlled trial', Antiviral Therapy, 23, pp. 21 - 32,
    Journal articles | 2017
    Amara AB; Else LJ; Carey D; Khoo S; Back DJ; Amin J; Emery S; Puls RL, 2017, 'Comparison of dried blood spots versus conventional plasma collection for the characterization of efavirenz pharmacokinetics in a large-scale global clinical trial-the ENCORE1 study', Therapeutic Drug Monitoring, 39, pp. 654 - 658,
    Journal articles | 2017
    Baker JV; Sharma S; Achhra AC; Bernardino JI; Bogner JR; Duprez D; Emery S; Gazzard B; Gordin J; Grandits G; Phillips AN; Schwarze S; Soliman EZ; Spector SA; Tambussi G; Lundgren J, 2017, 'Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial', Journal of the American Heart Association, 6, pp. e004987,
    Journal articles | 2017
    Baker JV; Sharma S; Grund B; Rupert A; Metcalf JA; Schechter M; Munderi P; Aho I; Emery S; Babiker A; Phillips A; Lundgren JD; Neaton JD; Lane HC, 2017, 'Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial', Open Forum Infectious Diseases, 4, pp. ofx262,
    Journal articles | 2017
    Boyd MA; Amin J; Mallon PWG; Kumarasamy N; Lombaard J; Wood R; Chetchotisakd P; Phanuphak P; Mohapi L; Azwa I; Belloso WH; Molina JM; Hoy J; Moore CL; Emery S; Cooper DA, 2017, 'Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study', The Lancet HIV, 4, pp. e13 - e20,
    Journal articles | 2017
    Lee WS; Kristensen AB; Rasmussen TA; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Mark Hogarth P; Reynaldi A; Davenport MP; Emery S; Amin J; Cooper DA; Kan VL; Fox J; Gruell H; Parsons MS; Kent SJ, 2017, 'Anti-HIV-1 ADCC antibodies following latency reversal and treatment interruption', Journal of Virology, 91, pp. 10.1128/jvi.00603 - 10.1128/jvi.00617,
    Journal articles | 2017
    Lee WS; Kristensen AB; Tolstrup M; Østergaard L; Søgaard OS; Wines BD; Hogarth PM; Reynaldi A; Davenport M; Emery S; Amin J; Cooper DA; Kan V; Fox J; Grüll H; Parsons MS; Kent SJ; Rasmussen TA, 2017, '13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption', Journal of Virus Eradication, 3, pp. 10 - 10,
    Journal articles | 2017
    Lifson AR; Grund B; Gardner EM; Kaplan R; Denning E; Engen N; Carey CL; Chen F; Dao S; Florence E; Sanz J; Emery S, 2017, 'Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection', AIDS, 31, pp. 953 - 963,
    Journal articles | 2017
    Madhavi V; Kulkarni A; Shete A; Lee WS; McLean MR; Kristensen AB; Ghate M; Wines BD; Hogarth PM; Parsons MS; Kelleher A; Cooper DA; Amin J; Emery S; Thakar M; Kent SJ, 2017, 'Effect of Combination Antiretroviral Therapy on HIV-1-specific Antibody-Dependent Cellular Cytotoxicity Responses in Subtype B- and Subtype C-Infected Cohorts', Journal of Acquired Immune Deficiency Syndromes, 75, pp. 345 - 353,
    Journal articles | 2017
    Madhavi V; Wines BD; Amin J; Emery S; Lopez E; Kelleher A; Center RJ; Mark Hogarth P; Chung AW; Kent SJ; Stratov I, 2017, 'HIV-1 Env- and Vpu-specific antibody-dependent cellular cytotoxicity responses associated with elite control of HIV', Journal of Virology, 91, pp. 10.1128/jvi.00700 - 10.1128/jvi.00717,
    Journal articles | 2017
    Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus Nordwall J; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Han A, 2017, 'Circulating MIR-122 and MIR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals', Scientific Reports, 7, pp. 10934,
    Journal articles | 2017
    Murray JM; Zaunders J; Emery S; Cooper DA; Hey-Nguyen WJ; Koelsch KK; Kelleher AD, 2017, 'HIV dynamics linked to memory CD4+ T cell homeostasis', PLoS ONE, 12, pp. e0186101,
    Journal articles | 2017
    Peterson RL; Vock DM; Powers JH; Emery S; Cruz EF; Hunsberger S; Jain MK; Pett S; Neaton JD, 2017, 'Analysis of an ordinal endpoint for use in evaluating treatments for severe influenza requiring hospitalization', Clinical Trials, 14, pp. 264 - 276,
    Journal articles | 2016
    Baker JV; Hullsiek KH; Engen NW; Nelson R; Chetchotisakd P; Gerstoft J; Jessen H; Losso M; Markowitz N; Munderi P; Papadopoulos A; Shuter J; Rappoport C; Pearson MT; Finley E; Babiker A; Emery S; Duprez D; Aagaard B; Borges H; Jansson PO; Neilsen BR; Arenas-Pinto A; Atako NB; Babiker AG; Dennis E; Forcat S; Hudson F; Jackson B; Maas D; Purvis C; Russell C; Carey C; Clewett M; Jacoby S; Sánchez A; Vjecha MJ, 2016, 'Early antiretroviral therapy at high CD4 counts does not improve arterial elasticity: A substudy of the strategic timing of antiretroviral treatment (START) trial', Open Forum Infectious Diseases, 3, pp. ofw213,
    Journal articles | 2016
    Boatman J; Baker J; Emery S; Mushatt D; Furrer H; Sedláček D; Lundgren J; Neaton J, 2016, 'Risk Factors for Low Immune Recovery Among Participants with CD4+ Counts > 500 cells/mm3 who Achieved Viral Suppression in the Immediate Antiretroviral Treatment (ART) Group in Strategic Timing of Antiretroviral Treatment (START) Trial', Open Forum Infectious Diseases, 3,
    Journal articles | 2016
    Bunupuradah T; Kiertiburanakul S; Avihingsanon A; Chetchotisakd P; Techapornroong M; Leerattanapetch N; Kantipong P; Bowonwatanuwong C; Banchongkit S; Klinbuayaem V; Mekviwattanawong S; Nimitvilai S; Jirajariyavej S; Prasithsirikul W; Munsakul W; Bhakeecheep S; Chaivooth S; Phanuphak P; Cooper DA; Apornpong T; Kerr SJ; Emery S; Ruxrungtham K, 2016, 'Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial', The Lancet HIV, 3, pp. e343 - e350,
    Journal articles | 2016
    Dickinson L; Amin J; Else L; Boffito M; Egan D; Owen A; Khoo S; Back D; Orrell C; Clarke A; Losso M; Phanuphak P; Carey D; Cooper DA; Emery S; Puls R, 2016, 'Comprehensive Pharmacokinetic, Pharmacodynamic and Pharmacogenetic Evaluation of Once-Daily Efavirenz 400 and 600mg in Treatment-Naïve HIV-Infected Patients at 96Weeks: Results of the ENCORE1 Study', Clinical Pharmacokinetics, 55, pp. 861 - 873,
    Journal articles | 2016
    Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR, 2016, 'Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV', Osteoporosis International, 27, pp. 1737 - 1745,
    Journal articles | 2016
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE, 2016, 'Pulmonary effects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial', The Lancet Respiratory Medicine, 4, pp. 980 - 989,
    Journal articles | 2016
    Lam EP; Moore CL; Gotuzzo E; Nwizu C; Kamarulzaman A; Chetchotisakd P; Van Wyk J; Teppler H; Kumarasamy N; Molina JM; Emery S; Cooper DA; Boyd MA, 2016, 'Antiretroviral resistance after first-line antiretroviral therapy failure in diverse HIV-1 subtypes in the SECOND-LINE study', AIDS Research and Human Retroviruses, 32, pp. 841 - 850,
    Journal articles | 2016
    Pett SL; Amin J; Horban A; Andrade-Villanueva J; Losso M; Porteiro N; Madero JS; Belloso W; Tu E; Silk D; Kelleher A; Harrigan R; Clark A; Sugiura W; Wolff M; Gill J; Gatell J; Fisher M; Clarke A; Ruxrungtham K; Prazuck T; Kaiser R; Woolley I; Arnaiz JA; Cooper D; Rockstroh JK; Mallon P; Emery S; Cooper D; Tu E; Silk D, 2016, 'Maraviroc, as a switch option, in HIV-1-infected individuals with stable, well-controlled HIV replication and R5-tropic virus on their first Nucleoside/Nucleotide reverse transcriptase inhibitor plus ritonavir-boosted protease inhibitor regimen: Week 48 Results of the randomized, multicenter March study', Clinical Infectious Diseases, 63, pp. 122 - 132,
    Journal articles | 2016
    Revell A; Khabo P; Ledwaba L; Emery S; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Reiss P; van Sighem A; Pozniak A; Montaner J; Lane HC; Larder B, 2016, 'Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa', SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE, 17,
    Journal articles | 2016
    Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers RL; Reiss P; van Sighem AI; Nelson M; Montaner JSG; Lane HC; Larder BA; Harrigan R; de Wit TR; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Kaiser R; Schuelter E; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Pozniak A; Mandalia S; Webster D; Smith C; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias MJ; Vella S; Dettorre G; Carr A; Norris R; Hesse K; Vlahakis E; Barth R; Hoffmann C; Ene L; Dragovic G; Diaz R; Sucupira C; Sued O; Cesar C; Madero JS; Emery S; Cooper D; Baxter J; Monno L; Picchio G; deBethune MP; Khabo P; Ledwaba L, 2016, 'An update to the HIV-TRePS system: The development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype', Journal of Antimicrobial Chemotherapy, 71, pp. 2928 - 2937,
    Journal articles | 2016
    Taychakhoonavudh S; Maneesawangwong N; Bunupuradah T; Kiertiburanakul S; Worrathammasorn T; Hadnorntun P; Avihingsanon A; Chetchotisakd P; Emery S; Ruxrungtham K, 2016, 'COST-UTILITY ANALYSIS OF ATAZANAVIR/RITONAVIR 200/100 MG VERSUS ATAZANAVIR/RITONAVIR 300/100 MG IN THAI ADULTS WITH VIROLOGIC SUPPRESSION', VALUE IN HEALTH, 19, pp. A912 - A912,
    Journal articles | 2015
    , 2015, '8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).', J Int AIDS Soc, 18, pp. 20479,
    Journal articles | 2015
    Achhra AC; Phillips A; Emery S; Macarthur RD; Furrer H; De Wit S; Losso M; Law MG; Han A, 2015, 'Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy', HIV Medicine, 16, pp. 449 - 454,
    Journal articles | 2015
    Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Nwizu C; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Avihingsanon A; Boyd M; Carey D; Clarke A; Courtney-Vega K; Delfino M; Donaldson A; Emery S; Espinosa N; Johannesen T; Lin E; Losso M; Moricz A; Pett S; Phanupak P; Puls R; Pussadee K; Sutheerasak P; Tomlins L; Ubolyam S; bin Raja Azwa RIS; Bissio E; Calanni L; Chetchotisakd P; Doong N; Elliott J; Gazzard B; Kelly M; Laplume H; del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Phanuphak P; Rockstroh J; Rowling D; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Dunn D; Dolan M; Emery S; Kelleher A, 2015, 'Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study', The Lancet Infectious Diseases, 15, pp. 793 - 802,
    Journal articles | 2015
    Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Erratum: Raltegravir Non-Inferior to Nucleoside Based Regimens in SECOND-LINE Therapy with Lopinavir/Ritonavir over 96 Weeks: A Randomised Open Label Study for the Treatment Of HIV-1 Infection (PLoS ONE (2015)10:2 (e0118228) Doi: 10.1371/journal.pone.0118228 ))', PLoS ONE, 10, pp. e0140623,
    Journal articles | 2015
    Amin J; Boyd MA; Kumarasamy N; Moore CL; Losso MH; Nwizu CA; Mohapi L; Kerr SJ; Sohn AH; Teppler H; Renjifo B; Molina JM; Emery S; Cooper DA, 2015, 'Raltegravir non-inferior to nucleoside based regimens in second-line therapy with lopinavir/ritonavir over 96 weeks: A randomised open label study for the treatment of HIV-1 infection', PLoS ONE, 10, pp. e0118228,
    Journal articles | 2015
    Berthon-Jones N; Courtney-Vega K; Donaldson A; Haskelberg H; Emery S; Puls R, 2015, 'Assessing site performance in the Altair study, a multinational clinical trial', Trials, 16,
    Journal articles | 2015
    Borges ÁH; O'Connor JL; Phillips AN; Rönsholt FF; Pett S; Vjecha MJ; French MA; Lundgren JD, 2015, 'Factors Associated with Plasma IL-6 Levels during HIV Infection', Journal of Infectious Diseases, 212, pp. 585 - 595,
    Journal articles | 2015
    Boyd MA; Moore CL; Molina JM; Wood R; Madero JS; Wolff M; Ruxrungtham K; Losso M; Renjifo B; Teppler H; Kelleher AD; Amin J; Emery S; Cooper DA, 2015, 'Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: An exploratory analysis', The Lancet HIV, 2, pp. e42 - e51,
    Journal articles | 2015
    Dickinson L; Amin J; Else L; Boffito M; Egan D; Owen A; Khoo S; Back D; Orrell C; Clarke A; Losso M; Phanuphak P; Carey D; Cooper DA; Emery S; Puls R, 2015, 'Pharmacokinetic and Pharmacodynamic Comparison of Once-Daily Efavirenz (400 mg vs. 600 mg) in Treatment-Naive HIV-Infected Patients: Results of the ENCORE1 Study', Clinical Pharmacology and Therapeutics, 98, pp. 406 - 416,
    Journal articles | 2015
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK; PINT study team ; Danta M, 2015, 'Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.', AIDS, 29, pp. 911 - 919,
    Journal articles | 2015
    Lundgren J; Babiker A; Gordin F; Emery S; Fätkenheuer G; Molina JM; Wood R; Neaton JD; Agan BK; Alston-Smith B; Arenas-Pinto A; Arribas JR; Baker JV; Baxter J; Belloso WH; Brekke K; Brew B; Brobst SW; Burman W; Carey C; Clark R; Cooper DA; Davey RT; De La Rosa G; Denning ET; Dolan M; Dore G; Duprez D; Emanuel E; Grady C; Grund B; Hirschel B; Hoen B; Hudson F; Johnson MA; Kambili C; Klingman K; Kunisaki KM; Landay A; Ledergerber B; Lehrman SN; Martinez A; Meger S; Misar K; Mitsuyasu RT; Mocroft A; Munroe D; Norton M; Palmer RC; Pett SL; Phillips A; Pillay D; Porter D; Price RW; Proschan M; Rappoport C; Reiss P; Renjifo B; Robertson K; Rockstroh J; Rodriguez G; Rooney JF; Ross MJ; Schechter M; Schwarze S; Seekins D; Sharma S; Snowden W; Telenti A; Tryon J; van Wyk J; Vjecha MJ; Wright E; Cooper D, 2015, 'Why START? Reflections that led to the conduct of this large long-term strategic HIV trial', HIV Medicine, 16, pp. 1 - 9,
    Journal articles | 2015
    Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Clifford Lane H; Phillips AN; Neaton JD; Kelleher A; Cysique L, 2015, 'Initiation of antiretroviral therapy in early asymptomatic HIV infection', New England Journal of Medicine, 373, pp. 795 - 807,
    Journal articles | 2015
    McFadden E; Bashir S; Canham S; Darbyshire J; Davidson P; Day S; Emery S; Pater J; Rudkin S; Stead M; Brown J, 2015, 'The impact of registration of clinical trials units: The UK experience', Clinical Trials, 12, pp. 166 - 173,
    Journal articles | 2015
    Murray DD; Suzuki K; Law M; Trebicka J; Neuhaus J; Wentworth D; Johnson M; Vjecha MJ; Kelleher AD; Emery S; Aagaard B; Aragon E; Arnaiz J; Borup L; Clotet B; Dragsted U; Fau A; Gey D; Grarup J; Hengge U; Herrero P; Jansson P; Jensen B; Jensen K; Juncher H; Lopez P; Lundgren JD; Matthews C; Mollerup D; Pearson M; Phillips A; Reilev S; Tillmann K; Varea S; Angus B; Babiker A; Cordwell B; Darbyshire J; Dodds W; Fleck S; Horton J; Hudson F; Moraes Y; Pacciarini F; Palfreeman A; Paton N; Smith N; Van Hooff F; Bebchuk J; Collins G; Denning E; DuChene A; Fosdick L; Harrison M; Herman-Lamin K; Krum E; Larson G; Neaton J; Nelson R; Quan K; Quan S; Schultz T; Thompson G; Wyman N; Carey C; Chan F; Cooper D; Courtney-Rodgers D; Drummond F; Harrod M; Jacoby S; Kearney L; Lin E; Pett S; Robson R; Seneviratne N; Stewart M; Watts E; Finley E; Gordin F; Sánchez A; Standridge B; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J; Modlin J; Beral V; Chaisson R; Fleming T; Hill C; Bloch M; Cooper D; Konecny P; Carr A; Medland N; Sullivan J; Han A, 2015, 'Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection: A case control study', PLoS ONE, 10, pp. e0139981,
    Journal articles | 2015
    Sharma S; Babiker A; Emery S; Gordin F; Lundgren J; Neaton J; Bakowska E; Schechter M; Wiselka M; Wolff M, 2015, 'Demographic and HIV-specific characteristics of participants enrolled in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 30 - 36,
    Journal articles | 2015
    Soliman E; Sharma S; Arastéh K; Wohl D; Achhra A; Tambussi G; O'Connor J; Stein J; Duprez D; Neaton J; Phillips A, 2015, 'Baseline cardiovascular risk in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial', HIV Medicine, 16, pp. 46 - 54,
    Journal articles | 2015
    Winston A; Amin J; Clarke A; Else L; Amara A; Owen A; Barber T; Jessen H; Avinghsanon A; Chetchotisakd P; Khoo S; Cooper DA; Emery S; Puls R; Puls R; Carey D; Cunningham P; Kelleher A, 2015, 'Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: A randomized controlled trial', Clinical Infectious Diseases, 60, pp. 1026 - 1032,
    Journal articles | 2015
    Winston A; Puls R; Kerr SJ; Duncombe C; Li P; Gill JM; Ramautarsing R; Taylor-Robinson SD; Emery S; Cooper DA; Belloso W; Gazzard B; Hung CC; Jessen H; Kamrulazaman A; Li L; Losso M; Sierra-Madero J; Mallon P; Mason B; Molina JM; Petoumenos K; Phanuphak P; Pollack S; Rooney J; Walmsley S; Wolff M, 2015, 'Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART', PLoS ONE, 10, pp. e0118608,
    Journal articles | 2014
    Amin J; Becker S; Belloso W; Boffito M; Cooper D; Crabtree-Ramirez B; Duncombe C; Emery S; Foulkes S; Hill A; Jessen H; Kumar S; Lee MP; Losso M; Nwizu C; Phanuphak P; Ripin D; Read T; Rooney J; Schaffer K; Shahar E; Winston A; Wolff M; Young B; Abela C; Boyd M; Carey D; Clarke A; Courtney-Vega K; Dazo C; Delfino M; Donaldson A; Espinosa N; Johannesen T; Kaew-On P; Lin E; Moricz A; Taylor J; Phanupak P; Puls RL; Pussadee K; Sutheerasak P; Tomkins L; Ubolyam S; Shah Bin Raja Azwa RI; Bissio E; Calanni L; Casiro A; Chetchotisakd P; Contarelli J; Doong N; Elliott J; Gazzard B; Kelly M; Del Carmen Luna N; Lupo S; Messina OG; Mohapi L; Moore R; Nolan D; Orrell C; Perez C; Pett S; Rockstroh J; Supparatpinyo K; Smith D; Villanueva JA; Vlahakis E; Kelleher T; Cunningham P; Merlin K; Yeung J; Shaik A; Fsadni B; Carrera A; Lograsso M; Gulick R; Crabtree-Ramiraz B; Winston E; Dunn D; Dolan M; Cooper D; Kelleher A, 2014, 'Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): A randomised, double-blind, placebo-controlled, non-inferiority trial', The Lancet, 383, pp. 1474 - 1482,
    Journal articles | 2014
    Amin J; Law MG; Puls R; Kelleher A; Cooper DA; Emery S; Han A, 2014, 'Comparison of central and local HIV-1 RNA quantification from two international clinical trials', AIDS, 28, pp. 2480 - 2483,
    Journal articles | 2014
    Bavinton BR; Jin F; Prestage G; Zablotska I; Koelsch KK; Phanuphak N; Grinsztejn B; Cooper DA; Fairley C; Kelleher A; Triffitt K; Grulich AE; Templeton D; Emery S, 2014, 'The Opposites Attract Study of viral load, HIV treatment and HIV transmission in serodiscordant homosexual male couples: Design and methods', BMC Public Health, 14, pp. 917,
    Journal articles | 2014
    Borges AH; O'Connor JL; Phillips AN; Baker JV; Vjecha MJ; Losso MH; Klinker H; Lopardo G; Williams I; Lundgren JD, 2014, 'Factors associated with D-dimer levels in HIV-infected individuals', PLoS ONE, 9,
    Journal articles | 2014
    Borges AH; Weitz JI; Collins G; Baker JV; Lévy Y; Davey RT; Phillips AN; Neaton JD; Lundgren JD; Deeks SG, 2014, 'Markers of inflammation and activation of coagulation are associated with anaemia in antiretroviral-treated HIV disease', AIDS, 28, pp. 1791 - 1796,
    Journal articles | 2014
    Cummins NW; Neuhaus J; Sainski AM; Strausbauch MA; Wettstein PJ; Lewin SR; Plana M; Rizza SA; Temesgen Z; Touloumi G; Freiberg M; Neaton J; Badley AD, 2014, 'Short communication: CD4 T cell declines occurring during suppressive antiretroviral therapy reflect continued production of Casp8p41', AIDS Research and Human Retroviruses, 30, pp. 476 - 479,
    Journal articles | 2014
    Dawood FZ; Roediger MP; Grandits G; Miller D; Fisher M; Zhang ZM; Hodder S; Hoy JF; Lundgren JD; Neaton JD; Soliman EZ, 2014, 'Determinants of developing widened spatial QRS-T angle in HIV-infected individuals: Results from the Strategies for Management of Antiretroviral Therapy [SMART] Study', Journal of Electrocardiology, 47, pp. 264 - 271,
    Journal articles | 2014
    Dooko CBA; De Wit S; Neuhaus J; Palfreeman A; Pepe R; Pankow JS; Neaton JD, 2014, 'Interleukin-6, high sensitivity C-reactive protein, and the development of type 2 diabetes among HIV-positive patients taking antiretroviral therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 538 - 546,
    Journal articles | 2014
    Haskelberg H; Cordery DV; Amin J; Kelleher AD; Cooper DA; Emery S; Post J, 2014, 'HLA Alleles association with changes in bone mineral density in HIV-1-infected adults changing treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e93333,
    Journal articles | 2014
    Haskelberg H; Mallon PWG; Hoy J; Amin J; Moore C; Phanuphak P; Ferret S; Belloso WH; Boyd MA; Cooper DA; Emery S, 2014, 'Bone mineral density over 96 weeks in adults failing first-line therapy randomized to raltegravir/lopinavir/ ritonavir compared with standard second-line therapy', Journal of Acquired Immune Deficiency Syndromes, 67, pp. 161 - 168,
    Journal articles | 2014
    Haskelberg H; Pocock N; Amin J; Ebeling PR; Emery S; Carr A; Post J; Medland N; Boyd M, 2014, 'Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudine', PLoS ONE, 9, pp. e94858,
    Journal articles | 2014
    Lucas GM; Cozzi-Lepri A; Wyatt CM; Post FA; Bormann AM; Crum-Cianflone NF; Ross MJ, 2014, 'Glomerular filtration rate estimated using creatinine, cystatin C or both markers and the risk of clinical events in HIV-infected individuals', HIV Medicine, 15, pp. 116 - 123,
    Journal articles | 2014
    Lynfield R; Davey R; Dwyer DE; Losso MH; Wentworth D; Cozzi-Lepri A; Herman-Lamin K; Cholewinska G; David D; Kuetter S; Ternesgen Z; Uyeki TM; Lane HC; Lundgren J; Neaton JD, 2014, 'Outcomes of influenza A(H1N1)pdm09 virus infection: Results from two international cohort studies', PLoS ONE, 9,
    Journal articles | 2014
    Miller CJ; Baker JV; Bormann AM; Erlandson KM; Hullsiek KH; Justice AC; Neuhaus J; Paredes R; Petoumenos K; Wentworth D; Winston A; Wolfson J; Neaton JD; Emery S, 2014, 'Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy', PLoS ONE, 9, pp. e95061,
    Journal articles | 2014
    Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK, 2014, 'HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy', Journal of Virology, 88, pp. 3516 - 3526,
    Journal articles | 2014
    Nordell AD; McKenna M; Borges AH; Duprez D; Neuhaus J; Neaton JD, 2014, 'Severity of Cardiovascular Disease Outcomes Among Patients With HIV Is Related to Markers of Inflammation and Coagulation', JOURNAL OF THE AMERICAN HEART ASSOCIATION, 3,
    Journal articles | 2014
    Peters L; Neuhaus J; Duprez D; Neaton JD; Tracy R; Klein MB; Mocroft A; Rockstroh J; Dore G; Lundgren JD; Emery S, 2014, 'Biomarkers of inflammation, coagulation and microbial translocation in HIV/HCV co-infected patients in the SMART study', Journal of Clinical Virology, 60, pp. 295 - 300,
    Journal articles | 2014
    Revell AD; Boyd MA; Wang D; Emery S; Gazzard B; Reiss P; van Sighem A; Montaner JS; Lane HC; Larder BA, 2014, 'A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy', HIV Medicine, 15, pp. 442 - 448,
    Journal articles | 2014
    Revell AD; Wang D; Wood R; Morrow C; Tempelman H; Hamers R; Alvarez-Uria G; Streinu-Cercel A; Ene L; Wensing A; Reiss P; van Sighem AI; Nelson M; Emery S; Montaner JSG; Lane HC; Larder BA; Reiss P; van Sighem A; Montaner J; Harrigan R; Rinke de Wit T; Hamers R; Sigaloff K; Agan B; Marconi V; Wegner S; Sugiura W; Zazzi M; Streinu-Cercel A; Alvarez-Uria G; Gatell J; Lazzari E; Gazzard B; Nelson M; Pozniak A; Mandalia S; Ruiz L; Clotet B; Staszewski S; Torti C; Lane C; Metcalf J; Perez-Elias M-J; Carr A; Norris R; Hesse K; Vlahakis E; Tempelman H; Barth R; Morrow C; Wood R; Ene L; Dragovic G; Cooper D; Torti C; Baxter J; Monno L; Torti C; Gatell J; Clotet B; Picchio G; deBethune M-P; Perez-Elias M-J, 2014, 'An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes', Journal of Antimicrobial Chemotherapy, 69, pp. 1104 - 1110,
    Journal articles | 2013
    Andrade BB; Hullsiek KH; Boulware DR; Rupert A; French MA; Ruxrungtham K; Montes ML; Price H; Barreiro P; Audsley J; Sher A; Lewin SR; Sereti I, 2013, 'Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses', Journal of Infectious Diseases, 207, pp. 1379 - 1388,
    Journal articles | 2013
    Baker JV; Brummel-Ziedins K; Neuhaus J; Duprez D; Cummins N; Dalmau D; DeHovitz J; Lehmann C; Sullivan A; Woolley I; Kuller L; Neaton JD; Tracy RP; INSIGHT SMART Study Team , 2013, 'HIV replication alters the composition of extrinsic pathway coagulation factors and increases thrombin generation.', Journal of the American Heart Association, 2,
    Journal articles | 2013
    Bjerk SM; Baker J; Emery S; Neuhaus JA; Angus BJ; Gordin F; Pett SL; Stephan C; Kunisaki KM, 2013, 'Biomarkers and Bacterial Pneumonia Risk in Patients with Treated HIV Infection: A Case-Control Study', PLoS ONE, 8, pp. e56249,
    Journal articles | 2013
    Borges AH; Silverberg MJ; Wentworth D; Grulich AE; Fätkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD, 2013, 'Predicting risk of cancer during HIV infection: The role of inflammatory and coagulation biomarkers', AIDS, 27, pp. 1433 - 1441,
    Journal articles | 2013
    Boyd MA, 2013, 'Ritonavir-boosted lopinavir plus nucleoside or nucleotide reverse transcriptase inhibitors versus ritonavir-boosted lopinavir plus raltegravir for treatment of HIV-1 infection in adults with virological failure of a standard first-line ART regimen (SECOND-LINE): A randomised, open-label, non-inferiority study', Lancet, 381, pp. 2091 - 2099,
    Journal articles | 2013
    Byakwaga H; Petoumenos K; Ananworanich J; Zhang F; Boyd MA; Sirisanthana T; Li PCK; Lee C; Mean CV; Saphonn V; Omar SFS; Pujari S; Phanuphak P; Lim PL; Kumarasamy N; Chen YMA; Merati TP; Sungkanuparph S; Ditangco R; Oka S; Tau G; Zhou J; Law MG; Emery S; Han A, 2013, 'Predictors of clinical progression in HIV-1-infected adults initiating combination antiretroviral therapy with advanced disease in the Asia-Pacific region: Results from the TREAT Asia HIV Observational Database', Journal of the International Association of Providers of AIDS Care, 12, pp. 270 - 277,
    Journal articles | 2013
    Davey Jr R; Lynfield R; Dwyer DE; Losso MH; Cozzi-Lepri A; Wentworth D; Lane HC; Dewar RL; Pett SL; Uyeki TM; Angus BJ; Cummins NW; Lundgren JD; Neaton JD, 2013, 'The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies', PLoS ONE, 8, pp. e57121,
    Journal articles | 2013
    Dawood FZ; Khan F; Roediger MP; Zhang ZM; Swaminathan S; Klinker H; Hoy J; Lundgren JD; Neaton JD; Soliman EZ, 2013, 'Electrocardiographic spatial QRS-T angle and incident cardiovascular disease in hiv-infected patients (from the Strategies for the Management of Antiretroviral Therapy [SMART] Study)', American Journal of Cardiology, 111, pp. 118 - 124,
    Journal articles | 2013
    Grund B; Wright EJ; Brew BJ; Price RW; Roediger MP; Bain MP; Hoy JF; Shlay JC; Vjecha MJ; Robertson KR, 2013, 'Improved neurocognitive test performance in both arms of the SMART study: Impact of practice effect', Journal of NeuroVirology, 19, pp. 383 - 392,
    Journal articles | 2013
    Gupta M; Miller CJ; Baker JV; Lazar J; Bogner JR; Calmy A; Soliman EZ; Neaton JD, 2013, 'Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection', American Journal of Cardiology, 111, pp. 760 - 764,
    Journal articles | 2013
    Kent SJ; Reece JC; Petravic J; Martyushev A; Kramski M; De Rose R; Cooper DA; Kelleher AD; Emery S; Cameron PU; Lewin SR; Davenport MP, 2013, 'The search for an HIV cure: Tackling latent infection', The Lancet Infectious Diseases, 13, pp. 614 - 621,
    Journal articles | 2013
    Martin A; Moore C; Mallon PWG; Hoy J; Emery S; Belloso W; Phanuphak P; Ferret S; Cooper DA; Boyd MA, 2013, 'Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy', AIDS, 27, pp. 2403 - 2411,
    Journal articles | 2013
    Martin A; Moore CL; Mallon PWG; Hoy JF; Emery S; Belloso WH; Phanuphak P; Ferret S; Cooper DA; Boyd MA; Second-Line Study Team , 2013, 'HIV lipodystrophy in participants randomised to lopinavir/ritonavir (LPV/r) +2-3 nucleoside/nucleotide reverse transcriptase inhibitors (N(t)RTI) or LPV/r + raltegravir as second-line antiretroviral therapy.', PloS one, 8,
    Journal articles | 2013
    Murray JM; Zaunders JJ; Koelsch KK; Natarajan V; Badralmaa Y; McBride K; Carrera A; Cooper DA; Emery S; Kelleher AD, 2013, 'Short communication: HIV blips while on antiretroviral therapy can indicate consistently detectable viral levels due to assay underreporting', AIDS Research and Human Retroviruses, 29, pp. 1621 - 1625,
    Journal articles | 2013
    O'Connor JL; Gardner EM; Mannheimer SB; Lifson AR; Esser S; Telzak EE; Phillips AN, 2013, 'Factors associated with adherence amongst 5295 people receiving antiretroviral therapy as part of an international trial', Journal of Infectious Diseases, 208, pp. 40 - 49,
    Journal articles | 2013
    Rodger AJ; Lodwick RK; Schechter M; Deeks SG; Amin J; Gilson RJC; Paredes R; Bakowska E; Engsig FN; Phillips AN, 2013, 'Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population', AIDS, 27, pp. 973 - 979,
    Journal articles | 2013
    Rotger M; Glass TR; Junier T; Lundgren J; Neaton JD; Poloni ES; Van 'T Wout AB; Lubomirov R; Colombo S; Martinez R; Rauch A; Günthard HF; Neuhaus J; Wentworth D; Van Manen D; Gras LA; Schuitemaker H; Albini L; Torti C; Jacobson LP; Li X; Kingsley LA; Carli F; Guaraldi G; Ford ES; Sereti I; Hadigan C; Martinez E; Arnedo M; Egaña-Gorroño L; Gatell JM; Law M; Bendall C; Petoumenos K; Rockstroh J; Wasmuth JC; Kabamba K; Delforge M; De Wit S; Berger F; Mauss S; De Paz Sierra M; Losso M; Belloso WH; Leyes M; Campins A; Mondi A; De Luca A; Bernardino I; Barriuso-Iglesias M; Torrecilla-Rodriguez A; Gonzalez-Garcia J; Arribas JR; Fanti I; Gel S; Puig J; Negredo E; Gutierrez M; Domingo P; Fischer J; Fätkenheuer G; Alonso-Villaverde C; MacKen A; Woo J; McGinty T; Mallon P; Mangili A; Skinner S; Wanke CA; Reiss P; Weber R; Bucher HC; Fellay J; Telenti A; Tarr PE, 2013, 'Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons', Clinical Infectious Diseases, 57, pp. 112 - 121,
    Journal articles | 2013
    Schneider K; Nwizu CA; Kaplan R; Anderson JS; Wilson DP; Emery S; Cooper DA; Boyd MA, 2013, 'The Potential Cost and Benefits of Raltegravir in Simplified Second-Line Therapy among HIV Infected Patients in Nigeria and South Africa', PLoS ONE, 8, pp. e54435,
    Journal articles | 2013
    Soliman EZ; Roediger MP; Duprez DA; Knobel H; Elion R; Neaton JD, 2013, 'Protease inhibitors and cardiac autonomic function in HIV-infected patients: a cross-sectional analysis from the Strategies for Management of Antiretroviral Therapy (SMART) Trial', BMJ OPEN, 3,
    Journal articles | 2013
    Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, 'Results of external quality assessment for proviral DNA testing of HIV tropism in the Maraviroc switch collaborative study', Journal of Clinical Microbiology, 51, pp. 2063 - 2071,
    Journal articles | 2012
    Achhra AC; Amin J; Sabin C; Chu H; Dunn D; Kuller LH; Kovacs JA; Cooper DA; Emery S; Law MG, 2012, 'Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individuals', AIDS, 26, pp. 1707 - 1717,
    Journal articles | 2012
    Babiker AG; Emery S; Faetkenheuer G; Gordin FM; Grund B; Lundgren JD; Neaton JD; Pett SL; Phillips A; Touloumi G; Vjecha MJ, 2012, 'Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study', CLINICAL TRIALS, pp. 1 - 32,
    Journal articles | 2012
    Baker JV; Neuhaus J; Duprez D; Freiberg M; Bernardino JI; Badley AD; Nixon DE; Lundgren JD; Tracy RP; Neaton JD, 2012, 'HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction', Journal of Acquired Immune Deficiency Syndromes, 60, pp. 128 - 134,
    Journal articles | 2012
    Carey DL; Pett SL; Bloch M; Wand H; MacRae K; Beileiter K; Ray J; Boyd MA; Emery S; Cooper DA, 2012, 'A randomized study of pharmacokinetics, efficacy, and safety of 2 raltegravir plus atazanavir strategies in ART-treated adults', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 60, pp. 143 - 149,
    Journal articles | 2012
    Cordery D; Martin A; Kelleher AD; Emery S; Cooper DA, 2012, 'The influence of HLA supertype on thymidine analogue associated with low peripheral fat in HIV.', AIDS, 26, pp. 2337 - 2344,
    Journal articles | 2012
    Crawford KW; Ripin DHB; Levin AD; Campbell JR; Flexner C, 2012, 'Optimising the manufacture, formulation, and dose of antiretroviral drugs for more cost-efficient delivery in resource-limited settings: A consensus statement', The Lancet Infectious Diseases, 12, pp. 550 - 560,
    Journal articles | 2012
    Duerr A; Huang Y; Buchbinder S; Coombs RW; Sanchez J; Del Rio C; Casapia M; Santiago S; Gilbert P; Corey L; Robertson MN, 2012, 'Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study)', Journal of Infectious Diseases, 206, pp. 258 - 266,
    Journal articles | 2012
    Duprez DA; Neuhaus J; Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon D; Paton NI; Prineas RJ; Neaton JD, 2012, 'Inflammation, coagulation and cardiovascular disease in HIV-infected individuals', PLoS ONE, 7,
    Journal articles | 2012
    Else L; Jackson A; Puls R; Hill A; Fahey P; Lin E; Amara A; Siccardi M; Watson V; Tjia JF; Emery S; Khoo SK; Back D; Boffito M, 2012, 'Pharmacokinetics of lamivudine and lamivudine-triphosphate after administration of 300 milligrams and 150 milligrams once daily to healthy volunteers: Results of the ENCORE 2 study', Antimicrobial Agents and Chemotherapy, 56, pp. 1427 - 1433,
    Journal articles | 2012
    Hamlyn E; Ewings FM; Porter K; Cooper DA; Tambussi G; Schechter MT; Pedersen C; Okulicz JF; Mcclure MO; Babiker AG, 2012, 'Plasma HIV Viral Rebound following Protocol-Indicated Cessation of ART Commenced in Primary and Chronic HIV Infection', PLoS ONE, 7, pp. Article numbere43754,
    Journal articles | 2012
    Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr AD, 2012, 'Changes in Bone Turnover and Bone Loss in HIV-Infected Patients Changing Treatment to Tenofovir-Emtricitabine or Abacavir-Lamivudine', PLoS ONE, 7, pp. e38377,
    Journal articles | 2012
    Ledwaba L; Tavel JA; Khabo P; Maja P; Qin J; Sangweni P; Liu X; Follmann D; Metcalf JA; Orsega S; Baseler B; Neaton JD; Lane HC, 2012, 'Pre-ART Levels of Inflammation and Coagulation Markers Are Strong Predictors of Death in a South African Cohort with Advanced HIV Disease', PLOS ONE, 7,
    Journal articles | 2012
    Murray JM; McBride K; Boesecke C; Bailey MR; Amin J; Suzuki K; Baker D; Zaunders JJ; Emery S; Cooper DA; Koelsch KK; Kelleher AD, 2012, 'Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards', AIDS, 26, pp. 543 - 550,
    Journal articles | 2012
    Winston A; Duncombe CJ; Li PCK; Gill JM; Kerr SJ; Puls R; Taylor-Robinson SD; Emery S; Cooper DA, 2012, 'Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.', Neuroradiology, 54, pp. 1331 - 1339,
    Journal articles | 2012
    Winston A; Puls R; Kerr SJ; Duncombe CJ; Li PCK; Gill JM; Taylor-Robinson SD; Emery S; Cooper DA, 2012, 'Dynamics of cognitive change in HIV-infected individuals commencing three different initial antiretroviral regimens: A randomized, controlled study', HIV Medicine, 13, pp. 245 - 251,
    Journal articles | 2011
    Baker J; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren JD; Nixon DE; Paton NI; Neaton JD, 2011, 'Changes in inflammatory and coagulation biomarkers: A randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 56, pp. 36 - 43,
    Journal articles | 2011
    Baker J; Neuhaus JA; Duprez D; Cooper DA; Hoy J; Kuller LH; Lampe FC; Liappis A; Friis-Moller N; Otvos J; Paton NI; Tracy R; Neaton JD, 2011, 'Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy', AIDS, 25, pp. 2133 - 2142,
    Journal articles | 2011
    Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I, 2011, 'Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death', Journal of Infectious Diseases, 203, pp. 1637 - 1646,
    Journal articles | 2011
    Byakwaga H; Purcell DJ; French MA; Amin J; Lewin S; Haskelberg H; Kelleher AD; Garsia RJ; Boyd MA; Cooper DA; Emery S, 2011, 'Intensification of antiretroviral therapy with raltegravir or addition of hyperimmune bovine colostrum in HIV-infected patients with suboptimal CD4 + T-cell response: A randomized controlled trial', Journal of Infectious Diseases, 204, pp. 1532 - 1540,
    Journal articles | 2011
    Cordery DV; Humphries A; Amin J; Kelleher AD; Emery S; Cooper DA, 2011, 'The influence of HLA supertype on thymidine analogue induced body composition changes in STEAL', ANTIVIRAL THERAPY, 16, pp. A20 - A21,
    Journal articles | 2011
    Cozzi-Lepri A; French MA; Baxter J; Okhuysen P; Plana M; Neuhaus J; Landay A, 2011, 'Resumption of HIV replication is associated with monocyte/macrophage derived cytokine and chemokine changes: results from a large international clinical trial', AIDS, 25, pp. 1207 - 1217,
    Journal articles | 2011
    Dlamini JN; Hu Z; Ledwaba J; Morris L; Maldarelli FM; Dewar RL; Highbarger HC; Somaroo H; Sangweni P; Follmann DA; Pau AK, 2011, 'Genotypic resistance at viral rebound among patients who received lopinavir/ritonavir-based or efavirenz-based first antiretroviral therapy in South Africa', Journal of Acquired Immune Deficiency Syndromes, 58, pp. 304 - 308,
    Journal articles | 2011
    Duprez DA; Neuhaus J; Tracy R; Kuller LH; Deeks SG; Orkin C; Stoehr A; Woolley IJ; Neaton JD, 2011, 'N-terminal-proB-type natriuretic peptide predicts cardiovascular disease events in HIV-infected patients', AIDS, 25, pp. 651 - 657,
    Journal articles | 2011
    Dwyer DE; Davey R; Losso MH; Lynfield R; Cozzi-Lepri A; Gey D; Herman-Lamin K; Hoppe A; Lane ; Lundgren JD; Neaton JD; Pett SL; Standridge B; Uyeki M; Wentworth D, 2011, 'Surveillance of illness associated with pandemic (H1N1) 2009 virus infection among adults using a global clinical site netwok approach: The INSIGHT FLU 002 and FLU 003 studies', Vaccine, 29, pp. B56 - B62,
    Journal articles | 2011
    Feeney ER; Chazallon C; O''brien N; Meiffredy V; Goodall R; Aboulker J; Cooper DA; Yeni PG; Mallon PW, 2011, 'Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial)', HIV Medicine, 12, pp. 602 - 609,
    Journal articles | 2011
    Fitzgerald DW; Janes H; Robertson M; Coombs R; Frank I; Gilbert P; Loufty M; Mehrotra D; Duerr A, 2011, 'An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1-infected male subjects: Results from a randomized placebo-controlled trial (The step study)', Journal of Infectious Diseases, 203, pp. 765 - 772,
    Journal articles | 2011
    Haskelberg H; Carr AD; Emery S, 2011, 'Bone turnover markers in HIV disease', AIDS Reviews, 13, pp. 240 - 250,
    Journal articles | 2011
    Haskelberg H; Hoy J; Amin J; Ebeling PR; Emery S; Carr A, 2011, 'Lower fat mass and lower bone formation predict greater bone loss with tenofovir in HIV-infected adults', ANTIVIRAL THERAPY, 16, pp. A6 - A7,
    Journal articles | 2011
    Jackson A; Hill A; Puls R; Else L; Amin J; Back D; Lin E; Khoo S; Emery S; Morley R; Gazzard B; Boffito M, 2011, 'Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100 mg, 200/150 mg and 200/50 mg twice daily in HIV-negative volunteers', Journal of Antimicrobial Chemotherapy, 66, pp. 635 - 640,
    Journal articles | 2011
    Koelsch KK; Boesecke C; Mcbride K; Gelgor L; Fahey P; Natarajan V; Baker D; Bloch M; Murray JM; Zaunders J; Emery S; Cooper DA; Kelleher AD, 2011, 'Impact of treatment with raltegravir during primary or chronic HIV infection on RNA decay characteristics and the HIV viral reservoir', AIDS, 25, pp. 2069 - 2078,
    Journal articles | 2011
    Martin A; Amin J; Emery S; Baker D; Carr AD; Cooper DA; Bloch M, 2011, 'Predictors of limb fat gain in HIV positive patients following a change to tenofovir-emtricitabine or Abacavir-Lamivudine', PLoS One, 6, pp. Article number e26885,
    Journal articles | 2011
    Matthews G; Manzini P; Hu Z; Khabo P; Maja P; Matchaba G; Sangweni P; Metcalf K; Pool N; Orsega S; Emery S, 2011, 'Impact of lamivudine on HIV and hepatitis B virus-related outcomes in HIV/hepatitis B virus individuals in a randomized clinical trial of antiretroviral therapy in southern Africa', AIDS, 25, pp. 1727 - 1735
    Journal articles | 2011
    Mocroft A; Lifson AR; Touloumi G; Neuhaus J; Fox Z; Palfreeman A; Vjecha MJ; Hodder S; De Wit S; Lundgren JD; Phillips AN, 2011, 'Haemoglobin and anaemia in the SMART study', Antiviral Therapy, 16, pp. 329 - 337,
    Journal articles | 2011
    Peters L; Neuhaus J; Mocroft A; Soriano V; Rockstroh J; Dore G; Puoti M; Tedaldi E; Clotet B; Kupfer B; Lundgren JD; Klein MB, 2011, 'Hyaluronic acid levels predict increased risk of non-AIDS death in hepatitis-coinfected persons interrupting antiretroviral therapy in the SMART study', Antiviral Therapy, 16, pp. 667 - 675,
    Journal articles | 2011
    Pett SL; Carey C; Lin E; Wentworth D; Lazovski J; Miro J; Gordin F; Angus B; Rodriguez-Barradas M; Rubio R; Tambussi G; Cooper DA; Emery S, 2011, 'Predictors of bacterial pneumonia in Evaluation of Subcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT)', HIV Medicine, 12, pp. 219 - 227,
    Journal articles | 2011
    Revell ; Wang ; Boyd MA; Emery S; Pozniak A; de WF; Harrigan R; Montaner JSG; Lane C; Larder B, 2011, 'The development of an expert system to predict virological response to HIV therapy as part of an online treatment support tool', AIDS, 25, pp. 1855 - 1863,
    Journal articles | 2011
    Sandler NG; Wand H; Roque A; Law M; Nason M; Nixon DE; Pedersen C; Ruxrungtham K; Lewin S; Emery S; Neaton JD; Brenchley JM; Deeks SG; Sereti I; Douek D, 2011, 'Plasma levels of soluble CD14 independently predict mortality in HIV infection', Journal of Infectious Diseases, 203, pp. 780 - 790,
    Journal articles | 2011
    Smith W; Grady C; Krohmal B; Lazovski J; Wendler D, 2011, 'Empirical evaluation of the need for 'on-going consent' in clinical research', AIDS, 25, pp. 107 - 114,
    Journal articles | 2011
    Soliman EZ; Lundgren JD; Roediger MP; Duprez DA; Temesgen Z; Bickel M; Shlay JC; Somboonwit C; Reiss P; Stein JH; Neaton JD, 2011, 'Boosted protease inhibitors and the electrocardiographic measures of QT and PR durations', AIDS, 25, pp. 367 - 377,
    Journal articles | 2011
    Soliman EZ; Prineas R; Roediger M; Duprez D; Boccara F; Boesecke C; Stephan C; Hodder S; Stein JH; Lundgren JD; Neaton JD, 2011, 'Prevalence and prognostic significance of ECG abnormalities in HIV-infected patients: Results from the Strategies for Management of Antiretroviral Therapy study', Journal of Electrocardiology, 44, pp. 779 - 785,
    Journal articles | 2011
    Wand HC; Carey DL; Calmy A; Law MG; Cooper DA; Emery S; Carr AD, 2011, 'Prospective evidence that HIV lipoatrophy and visceral adiposity are partially independent processes', Open Access Journal of Clinical Trials, 3, pp. 1 - 7,
    Journal articles | 2010
    Achhra A; Amin J; Law MG; Emery S; Gerstoft J; Gordin F; Vjecha M; Neaton JD; Cooper DA, 2010, 'Immunodeficiency and the risk of serious clinical endpoints in a well-studied cohort of treated HIV-infected patients.', AIDS, 24, pp. 1877 - 1886
    Journal articles | 2010
    Amin J; De lazzari E; Emery S; Martin A; Martinez E; Carr AD; Gatell J; Cooper DA, 2010, 'Simplification with fixed-dose tenofovir-emtricitabine or abacavir-lamivudine in treatment experienced, virologically suppressed adults with HIV infection: combined analysis of two randomised, non-inferiority trials Bicombo and Steal.', Journal of AIDS & Clinical Research, 1, pp. 1001 - 1013,
    Journal articles | 2010
    Carey DL; Amin J; Boyd MA; Petoumenos K; Emery S, 2010, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomised controlled trials', Journal of Antimicrobial Chemotherapy, 65, pp. 1878 - 1888
    Journal articles | 2010
    Dore GJ; Soriano V; Rockstroh J; Kupfer B; Tedaldi E; Peters L; Neuhaus J; Puoti M; Klein M; Mocroft A; Clotet B; Lundgren JD, 2010, 'Frequent hepatitis B virus rebound among HIV–hepatitis B virus-coinfected patients following antiretroviral therapy interruption', AIDS, 24, pp. 857 - 865
    Journal articles | 2010
    French MA; Tanaskovic S; Law MG; Lim A; Fernandez S; Ward LD; Kelleher AD; Emery S, 2010, 'Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcγRIIa genotype', AIDS, 24, pp. 1938 - 1990
    Journal articles | 2010
    French MA; Tanaskovic S; Law MG; Lim A; Fernandez S; Ward LD; Kelleher AD; Emery S, 2010, 'Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a 'high-affinity' FcγRIIa genotype', AIDS, 24, pp. 1983 - 1990,
    Journal articles | 2010
    Hassim S; Shaw PA; Sangweni P; Malan L; Ntshani E; Mathibedi MJ; Stubbs N; Metcalf JA; Eckes R; Masur H; Komati S, 2010, 'Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples', Clinical Infectious Diseases, 50, pp. 1053 - 1059,
    Journal articles | 2010
    Hemachandra A; Puls R; Sirivichayakul S; Kerr SJ; Thantiworasit P; Ubolyam S; Cooper DA; Emery S; Phanuphak P; Kelleher AD; Ruxrungtham K, 2010, 'An HIV-1 clade A/E DNA prime, recombinant fowlpox virus boost vaccine is safe, but non-immunogenic in a randomized phase I/IIa trial in Thai volunteers at low risk of HIV infection', Human Vaccines, 6, pp. 835 - 840
    Journal articles | 2010
    Lampe FC; Duprez DA; Kuller LH; Tracy R; Otvos J; Stroes E; Cooper DA; Hoy J; Paton NI; Friis-Moller N; Neuhaus J; Liappis AP; Phillips AN, 2010, 'Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 54, pp. 275 - 284
    Journal articles | 2010
    Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials', HIV Clinical Trials, 11, pp. 205 - 219,
    Journal articles | 2010
    Lifson AR; Neuhaus J; Ramon Arribas J; van den Berg-Wolf M; Labriola AM; Read TRH, 2010, 'Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial', AMERICAN JOURNAL OF PUBLIC HEALTH, 100, pp. 1896 - 1903,
    Journal articles | 2010
    Martin A; Amin J; Cooper DA; Carr AD; Kelleher AD; Bloch M; Baker D; Woolley I; Emery S, 2010, 'Abacavir does not affect circulating levels of inflammatory or coagulopathic biomarkers in suppressed HIV: a randomized clinical trial', AIDS, 24, pp. 2657 - 2663
    Journal articles | 2010
    Martinez E; Visnegarwala F; Grund B; Thomas A; Gibert C; Shlay J; Drummond F; Pearce D; Edwards S; Reiss P; El-Sadr W; Carr AD, 2010, 'The effects of intermittent, CD4-guided antiretroviral therapy on body composition and metabolic parameters', AIDS, 24, pp. 353 - 363
    Journal articles | 2010
    Neaton JD; Neuhaus J; Emery S, 2010, 'Soluble biomarkers and morbidity among people infected with HIV: summary of published reports from 1997 to 2010', Current opinion in HIV & AIDS, 5, pp. 480 - 490
    Journal articles | 2010
    Neuhaus J; Angus B; Kowalska JD; La Rosa A; Sampson J; Wentworth D; Mocroft A, 2010, 'Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV', AIDS, 24, pp. 697 - 706,
    Journal articles | 2010
    Neuhaus J; Jacobs DR; Baker JV; Calmy A; Duprez D; La Rosa A; Kuller LH; Pett SL; Ristola M; Ross M; Shlipak MG; Tracy R; Neaton JD, 2010, 'Markers of inflammation, coagulation and renal function are elevated in adults with HIV infection', Journal of Infectious Diseases, 201, pp. 1788 - 1795
    Journal articles | 2010
    Pett SL; Emery S; Kelleher AD; Cooper DA, 2010, 'Antiretroviral agents: Focus on Maraviroc for the Treatment of HIV-1-Infected Adults', Clinical Medicine Insights: Therapeutics, 2, pp. CMT.S5420 - CMT.S5420,
    Journal articles | 2010
    Pett SL; Emery S; Kelleher AD; Cooper DA, 2010, 'Antiretroviral agents: Focus on maraviroc for the treatment of HIV-1-infected adults', Clinical Medicine Insights: Therapeutics, 2, pp. 697 - 713,
    Journal articles | 2010
    Pett SL; Kelleher AD; Emery S, 2010, 'Role of interleukin-2 inpatients with HIV infection', Drugs, 70, pp. 1115 - 1130
    Journal articles | 2010
    Pett SL; Zaunders J; Bailey M; Murray JM; Macrae K; Emery S; Cooper DA; Kelleher AD, 2010, 'A novel Chemokine-Receptor-5 (CCR5) blocker, SCH532706, has differential effects on CCR5+CD4+ and CCR5+CD8+ T cell numbers in chronic HIV infection', AIDS Research and Human Retroviruses, 26, pp. 653 - 661,
    Journal articles | 2010
    Puls R; Srasuebkul P; Petoumenos K; Boesecke C; Duncombe CJ; Belloso WH; Molina J; Li L; Avihingsanon A; Gazzard B; Cooper DA; Emery S, 2010, 'Efavirenz versus boosted atazanavir or zidovudine and abacavir in antirectroviral treatment-naive, HIV-infected subjects: week 48 data from the Altair study', Clinical Infectious Diseases, Oct 1; 51, pp. 855 - 864
    Journal articles | 2010
    Ratsela A; Polis M; Dhlomo S; Emery S; Grandits G; Khabo P; Khanyile T; Komati S; Neaton JD; Naidoo LC; Magongoa D; Qolohle D, 2010, 'A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count', Journal of Infectious Diseases, 202, pp. 1529 - 1537
    Journal articles | 2010
    Sellier P; Lafuente-Lafuente C; Bergmann J-F, 2010, 'Interleukin-2 Therapy in Patients with HIV Infection', NEW ENGLAND JOURNAL OF MEDICINE, 362, pp. 270 - 271,
    Journal articles | 2010
    Tavel JA; Babiker A; Carey C; Fisher M; Fox L; Gey D; Lopardo GD; Lopez JC; Markowitz N; Munroe D; Paton N; Ruxrungtham K; Standridge B; Wentworth D; Wyman N; Aagaard B; Borup L; Grarup J; Jansson PO; Jensen K; Lundgren J; Mollerup D; Reilev S; Braimah N; Darbyshire J; Horton J; King E; Smith N; Van Hooff F; Cooper DA; Courtney-Rodgers D; Emery S; Finley E; Gordin F; Sánchez A; Thomas D; Bebchuk J; Bollenbeck P; Denning E; DuChene AG; Fosdick L; Harrison M; Krum E; Larson G; Neaton JD; Nelson R; Quan K; Quan SFL; Schultz T; Thompson G; Collins S; Haerry DH; Meulbroek M; Peavy D; Rappoport C; Schwarze S; Valdez M; Watson J; Belloso WH; Davey R; Duprez D; Gatell JM; Hoy J; Lifson A; Pederson C; Perez G; Price R; Prineas R; Rhame F; Sampson JH; Worley J; Modlin JF; Beral V; Chaisson RE; Fleming TR; Hill C; Kim KM; Murray BE; Pick B; Seligmann M; Weller I; Luzar MA; Martinez A; Costas V; Eckstrand J; Brown S; Lupo SH; Losso MH; Anderson J; Chuah J; Kelly M; Orth D; Wolff MJ; Rusconi S; Tambussi G; Horban A; Antunes F; Mansinho K; Da Conceicao Vera JAV; Himmich H, 2010, 'Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: The STALWART study', PLoS ONE, 5,
    Journal articles | 2010
    Winston A; Duncombe C; Li P; Gill JM; Kerr SJ; Puls R; Petoumenos K; Taylor-Robinson SD; Emery S; Cooper DA, 2010, 'Does choice of combination antiretroviral therapy (cART) alter changes in cerebral function testing after 48 weeks in treatment-naive, HIV-1-infected individuals commencing cART? A randomized, controlled study', Clinical Infectious Diseases, 50, pp. 920 - 929
    Journal articles | 2010
    Wright EJ; Grund B; Robertson K; Brew BJ; Roediger M; Bain MP; Drummond F; Vjecha MJ; Hoy J; Miller C; Penalva de Oliveira AC; Pumpradit W; Shlay JC; El-Sadr W; Price RW, 2010, 'Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons', Neurology, 75, pp. 864 - 873
    Journal articles | 2009
    Abrams A; Levy Y; Losso MH; Babiker AG; Collins G; Cooper DA; Darbyshire JH; Emery S; Fox L; Gordin F; Lane HC; Lundgren JD; Mitsuyasu R; Neaton J; Phillips AN; Routy J; Tambussi G; Wentworth D, 2009, 'Interleukin-2 therapy in patients with HIV infection.', New England Journal of Medicine, 361, pp. 1548 - 1559
    Journal articles | 2009
    Boyd MA; Emery S; Cooper DA, 2009, 'Antiretroviral roll-out: the problem of second-line therapy', Lancet, 374, pp. 185 - 186
    Journal articles | 2009
    Byakwaga H; Boesecke C; Emery S, 2009, 'Inflammation and gut permeability', Journal of Hiv Therapy, 14, pp. 57 - 60,
    Journal articles | 2009
    Byakwaga H; Murray JM; Petoumenos K; Kelleher AD; Law MG; Boyd MA; Emery S; Mallon PW; Cooper DA, 2009, 'Evolution of CD4+T cell count in HIV-1-infected adults receiving antiretroviral therapy with sustained long-term virological suppression', AIDS Research and Human Retroviruses, 25, pp. 569 - 576
    Journal articles | 2009
    Byakwaga H; Zhou J; Petoumenos K; Law MG; Boyd MA; Emery S; Cooper DA; Mallon PW, 2009, 'Effect of nucleoside reverse transcriptase inhibitors on CD4 T-cell recovery in HIV-1-infected individuals receiving long-term fully suppressive combination antiretroviral therapy', HIV Medicine, 10, pp. 143 - 151
    Journal articles | 2009
    Carey DL; Baker D; Petoumenos K; Chuah J; Rogers G; Watson J; Cooper DA; Emery S; Carr AD, 2009, 'Poly-L-lactic acid for HIV-1 facial lipoatrophy: 48-week follow-up', HIV Medicine, 10, pp. 163 - 172
    Journal articles | 2009
    Duprez D; Kuller LH; Tracy R; Otvos J; Cooper DA; Hoy JF; Neuhaus J; Paton N; Friis-Moller N; Lampe F; Liappis A; Neaton JD, 2009, 'Lipoprotein particle subclasses, cardiovascular disease and HIV infection', Atherosclerosis, 207, pp. 524 - 529,
    Journal articles | 2009
    Emery S; Winston A, 2009, 'Raltegravir: a new choice in HIV and new chances for research', Lancet, 374, pp. 764 - 766
    Journal articles | 2009
    Grulich AE, 2009, 'Cancer: The effects of HIV and antiretroviral therapy, and implications for early antiretroviral therapy initiation', Current opinion in HIV & AIDS, 4, pp. 183 - 187
    Journal articles | 2009
    Grund B; Neuhaus J; Phillips A, 2009, 'Relative risk of death in the SMART study', LANCET INFECTIOUS DISEASES, 9, pp. 724 - 725,
    Journal articles | 2009
    Grund B; Peng G; Gibert C; Hoy JF; Isaksson R; Shlay J; Martinez E; Reiss P; Visnegarwala F; Carr AD, 2009, 'Continuous antiretroviral therapy decreases bone mineral density', AIDS, 23, pp. 1519 - 1529
    Journal articles | 2009
    Hemachandra A; Puls RL; Kerr SJ; Saengthong N; Pussadee K; Emery S; Phanuphak P; Ruxrungtham K, 2009, 'P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand', Retrovirology, 6,
    Journal articles | 2009
    Lazovski J; Losso M; Krohmal B; Emanuel EJ; Grady C; Wendler D, 2009, 'BENEFITS AND BURDENS OF PARTICIPATION IN A LONGITUDINAL CLINICAL TRIAL', JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS, 4, pp. 89 - 97,
    Journal articles | 2009
    Martin A; Bloch MT; Amin J; Baker DL; Cooper DA; Emery S; Carr AD, 2009, 'Simplification of Antiretroviral Therapy with Tenofovir-Emtricitabine or Abacavir-Lamivudine: A Randomized, 96-Week Trial', Clinical Infectious Diseases, 49, pp. 1591 - 1601
    Journal articles | 2009
    Martin A; Emery S, 2009, 'Metabolic disorders and cardiovascular consequences of HIV infection and antiretroviral therapy', Expert Review of Clinical Pharmacology, 2, pp. 381 - 390
    Journal articles | 2009
    Mocroft A; Wyatt C; Szczech L; Neuhaus J; El-Sadr W; Tracy R; Kuller L; Shlipak M; Angus B; Klinker H; Ross M, 2009, 'Interruption of antiretroviral therapy is associated with increased plasma cystatin C', AIDS, 23, pp. 71 - 82,
    Journal articles | 2009
    Pett SL; Mccarthy M; Cooper DA; MacRae K; Tendolkar A; Norris R; Strizki J; Williams KM; Emery S, 2009, 'A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients', Antiviral Therapy, 14, pp. 111 - 115
    Journal articles | 2009
    Pett SL, 2009, 'Immunotherapies in HIV-1 infection', Current opinion in HIV & AIDS, 4, pp. 188 - 193
    Journal articles | 2009
    Phillips A; Emery S, 2009, 'Editorial introductions', Current Opinion in HIV and AIDS, 4,
    Journal articles | 2009
    Phillips A; Emery S, 2009, 'Predicting the potential benefits of early initiation of ART: Time to do a trial to find out', Current opinion in HIV & AIDS, 4, pp. 165 - 166
    Journal articles | 2009
    Read TRH; Carey DL; Mallon PW; Mijch A; Goodall R; Hudson F; Wand HC; Emery S, 2009, 'Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial', AIDS, 23, pp. 2222 - 2223,
    Journal articles | 2009
    Rodger A; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis ; Goetz M; Phillips AN, 2009, 'Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection', Journal of Infectious Diseases, 200, pp. 973 - 983,
    Journal articles | 2009
    Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2009, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition, visceral fat, lipid, glucose and adipokine metabolism', Current HIV Research, 7, pp. 454 - 461
    Journal articles | 2009
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C, 2009, 'A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy', Artificial Intelligence in Medicine, 47, pp. 63 - 74,
    Journal articles | 2009
    Zaunders J; Munier ML; Seddiki N; Pett SL; Ip S; Bailey M; Xu Y; Brown KJ; Dyer W; Kim MS; De Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD, 2009, 'High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40)', Journal of Immunology, 183, pp. 2827 - 2836,
    Journal articles | 2008
    Burman W; Grund B; Neuhaus J; Douglas J; Friedland G; Telzak E; Colebunders R; Paton N; Fisher M; Rietmeijer C, 2008, 'Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: Results of a randomized controlled trial', JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 49, pp. 142 - 150,
    Journal articles | 2008
    Byakwaga H; Murray JM; Petoumenos K; Boyd MA; Emery S; Mallon PW; Cooper DA, 2008, 'Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression', Journal of the International AIDS Society, 11,
    Journal articles | 2008
    Calmy A; Carey DL; Mallon PW; Wand HC; Law MG; Cooper DA; Carr AD, 2008, 'Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy', HIV Medicine, 9, pp. 101 - 110,
    Journal articles | 2008
    Carey DL; Liew S; Emery S, 2008, 'Restorative interventions for HIV facial lipoatrophy', AIDS Reviews, 10, pp. 116 - 124
    Journal articles | 2008
    Cooper DA; Emery S; Cordery D, 2008, 'Disease progression and fatal outcomes in HIV-infected patients during interruption of antiretroviral treatment', Journal of Infectious Diseases, 197, pp. 775 - 775,
    Journal articles | 2008
    El-Sadr W; Grund B; Neuhaus J; Babiker AG; Cohen C; Darbyshire JH; Emery S; Phillips A; Lundgren JD; Neaton JD, 2008, 'Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy - a randomized trial', Annals of Internal Medicine, 149, pp. 289 - W62
    Journal articles | 2008
    Emery S; Neuhaus J; Phillips A; Babiker AG; Cohen C; Gatell J; Girard P; Grund B; Law MG; Losso MH; Palfreeman A; Wood R, 2008, 'Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study', Journal of Infectious Diseases, 197, pp. 1133 - 1144,
    Journal articles | 2008
    Fox Z; Phillips AN; Cohen C; Neuhaus J; Baxter J; Emery S; Hirschel B; Hullsiek K; Stephan C; Lundgren JD, 2008, 'Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen', AIDS, 22, pp. 2279 - 2289
    Journal articles | 2008
    Gordin FM; Roediger MP; Girard P-M; Lundgren JD; Miro JM; Palfreeman A; Rodriguez-Barradas MC; Wolff MJ; Easterbrook PJ; Clezy K; Slater LN, 2008, 'Pneumonia in HIV-infected persons - Increased risk with cigarette smoking and treatment interruption', AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 178, pp. 630 - 636,
    Journal articles | 2008
    Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren JD; Neuhaus J; Nixon D; Paton N; Neaton JD, 2008, 'Inflammatory and Coagulation Biomarkers and Mortality in Patients with HIV Infection', PLOS Medicine, 5, pp. 1496 - 1508
    Journal articles | 2008
    Lifson A; Belloso WH; Carey C; Davey R; Duprez D; El-Sadr W; Gatell J; Gey D; Hoy JF; Krum E; Nelson R; Nixon D; Paton N; Pedersen C; Perez G; Price RA; Prineas R; Rhame F; Sampson J; Worley J, 2008, 'Determination of the underlying cause of death in three multicenter international HIV clinical trials', HIV Clinical Trials, 9, pp. 177 - 185,
    Journal articles | 2008
    Lundgren JD; Babiker AG; El-Sadr W; Emery S; Grund B; Neaton JD; Neuhaus J; Phillips A, 2008, 'Inferior clinical outcome of the CD4(+) cell count guided antiretroviral treatment interruption strategy in the SMART study: Role of CD4(+) cell counts and HIV RNA levels during follow-up', Journal of Infectious Diseases, 197, pp. 1145 - 1155,
    Journal articles | 2008
    Lundgren JD; Neuhaus J; Babiker AG; Cooper DA; Duprez D; El-Sadr W; Emery S; Gordin F; Kowalska J; Prineas R; Reiss P; Sabin C; Tracy R; Weber R; Grund B; Phillips AN; Neaton JD, 2008, 'Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients.', AIDS, 22, pp. F17 - F24,
    Journal articles | 2008
    Mallon PW; Sedwell R; Rogers GJ; Nolan D; Unemori P; Hoy JF; Samaras K; Kelleher AD; Emery S; Cooper DA; Carr AD, 2008, 'Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction', Journal of Infectious Diseases, 198, pp. 1794 - 1803
    Journal articles | 2008
    Mangclaviraj S; Kerr SJ; Chaithongwongwatthana S; Ananworanich J; Hirschel B; Emery S; Cooper DA; Chotnopparatpattara P; Ruxrungtham K; Phanuphak P, 2008, 'Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting', International Journal of STD and AIDS, 19, pp. 529 - 532
    Journal articles | 2008
    McElrath MJ; De Rosa SC; Moodie Z; Dubey S; Kierstead L; Janes H; Defawe OD; Carter DK; Hural J; Akondy R; Buchbinder SP; Robertson MN; Mehrotra DV; Self SG; Corey L; Shiver JW; Casimiro DR, 2008, 'HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis', The Lancet, 372, pp. 1894 - 1905,
    Journal articles | 2008
    Pett S; Zaunders J; Bailey M; Cooper D; MacRae K; Emery S; Kelleher A, 2008, 'Changes in CCR5+ cells and antigen-specific CD4+ T-cells during monotherapy with a CCR5 antagonist SCH532706 compared with combination therapy', Journal of the International AIDS Society, 11, pp. p297,
    Journal articles | 2008
    Phillips AN; Carr AD; Neuhaus J; Visnegarwala F; Prineas R; Burman W; Williams IR; Drummond F; Duprez D; Belloso WH; Goebel F; Grund B; Hatzakis A; Vera J; Lundgren JD, 2008, 'Interruption of antiretroviral therapy and risk of cardiovascular disease in persons with HIV-1 infection: exploratory analyses from the SMART trial', Antiviral Therapy, 13, pp. 177 - 187
    Journal articles | 2008
    Tedaldi E; Peters L; Neuhaus J; Puoti M; Rockstroh J; Klein M; Dore GJ; Mocroft A; Soriano V; Clotet B; Lundgren JD, 2008, 'Opportunistic Disease and Mortality in Patients Coinfected with Hepatitis B or C Virus in the Strategic Management of Antiretroviral Therapy (SMART) Study', Clinical Infectious Diseases, 47, pp. 1468 - 1475
    Journal articles | 2008
    Winters B; Montaner JS; Harrigan PR; Gazzard B; Pozniak A; Miller MD; Emery S; van Leth F; Robinson P; Baxter J; Perez-Elias M; Castor D; Hammer SM; Rinehart A; Vermeiren H; Van Craenenbroeck E; Bacheler L, 2008, 'Determination of clinically relevant cutoffs for HIV-1 phenotypic resistance estimates through a combined analysis of clinical trial and cohort data', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 48, pp. 26 - 34
    Journal articles | 2007
    Bucciardini R; Fragola V; Massella M; Polizzi C; Mirra M; Goodall RL; Carey DL; Hudson FE; Zajdenverg R; Floridia M, 2007, 'Health-related quality of life outcomes in HIV-Infected patients starting different combination regimens in a randomized multinational trial: The INITIO-QoL substudy', AIDS Research and Human Retroviruses, 23, pp. 1215 - 1222,
    Journal articles | 2007
    Byakwaga H; Zhou J; Law MG; Emery S; Mallon PW; Cooper DA, 2007, 'Effect of nucleoside reverse transcriptase inhibitors (NRTIs) on CD4 recovery for individuals on long-term, fully suppressive antiretroviral therapy (ART)', Antiviral Therapy, 12, pp. L61 - L62,
    Journal articles | 2007
    Carey DL; Baker D; Rogers G; Petoumenos K; Chuah J; Easey N; Mahon K; Cooper DA; Emery S; Carr AD, 2007, 'A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 46, pp. 581 - 589
    Journal articles | 2007
    Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59
    Journal articles | 2007
    Ellis KJ; Grund B; Visnegarwala F; Thackeray L; Miller CG; Chesson CE; El-Sadr W; Carr A, 2007, 'Visceral and subcutaneous adiposity measurements in adults: Influence of measurement site', Obesity, 15, pp. 1441 - 1447,
    Journal articles | 2007
    Emery S; Kelleher AD; Workman C; Puls R; Bloch MT; Baker D; Hoy JF; Ip S; Nalliah K; Ward L; Law MG; Cooper DA, 2007, 'Influence of IFN gamma co-expression on the safety and antiviral efficacy of recombinant fowlpox virus HIV therapeutic vaccines following interruption of antiretroviral therapy', Human Vaccines, 3, pp. 260 - 267
    Journal articles | 2007
    Fox Z; Antunes F; Davey R; Gazzard B; Klimas N; Labriola A; Losso M; Neaton JD; Phillips A; Ruxrungtham K; Staszewski S; Weiss L; Lundgren DJ; Aguilar L; Angel EB; Aquilia S; Belloso W; Benetucci J; Bittar V; Cahn P; Casiro A; Contarelli J; Corral J; Daciuk L; David D; Ferrari I; Fridman D; Galache V; Guaragna G; Ivalo S; Laplume H; Lanusse I; Lasala MB; Lattes R; Lasovsky J; Lopardo G; Lourtau L; Lupo S; Maranzana A; Marson C; Massera L; Sanchez MDL; Somenzini C; Tocci M; Algar S; Anderson J; Baker D; Blavius K; Bloch M; Boyle M; Bradford D; Britton P; Carrall L; Carr A; Chuah J; Curry M; D'Arcy-Evans C; Dobson P; Doong N; Egan C; Ferguson W; Finlayson R; French M; Frater A; Gold J; Habel P; Haig K; Holland R; Hyland N; Hoy J; Hudson J; James R; Leung J; Lowe K; MacRae K; McMurchie M; Medland N; Miller S; Murray J; Newman R; David O; Patching J; Primrose R; Ree H; Richardson R; Rogers G; Roney J; Roth N; Sarangapany J; Shaw D; Silberberg C; Skett A; Vale R; Villella C; Walker A; Watson A; Wendt N; Wood H, 2007, 'Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count ≥ 300 cells/μL who were assigned to 7.5 MIU interleukin-2', HIV Medicine, 8, pp. 112 - 123,
    Journal articles | 2007
    Larder BA; Wang D; Revell A; Montaner JS; Harrigan R; De Wolf F; Lange JM; Wegner S; Ruiz L; Perez-Elias M; Emery S; Gatell J; d Arminio Monforte A; Torti C; Zazzi M; Lane C, 2007, 'The development of artificial neural networks to predict virological response to combination HIV therapy', Antiviral Therapy, 12, pp. 15 - 24
    Journal articles | 2007
    Motumi N; Emery S; Lane C, 2007, 'Project phidisa: development of clinical research capacity within the South African National Defence Force', Current opinion in HIV & AIDS, 2, pp. 69 - 76
    Journal articles | 2007
    Murray JM; Emery S; Kelleher AD; Law MG; Chen J; Hazuda DJ; Nguyen BT; Teppler H; Cooper DA, 2007, 'Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase', AIDS, 21, pp. 2315 - 2321
    Journal articles | 2007
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Erratum: Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: Associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (Diabetes Care (2007) 30, (113-119))', Diabetes Care, 30, pp. 455,
    Journal articles | 2007
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A, 2007, 'Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and hypoadiponectinemia (vol 30, pg 113, 2007)', DIABETES CARE, 30, pp. 455 - 455,
    Journal articles | 2007
    Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2007, 'Prevalence of Metabolic Syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria', Diabetes Care, 30, pp. 113 - 119,
    Journal articles | 2007
    Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI, 2007, 'Risk of cancers during interrupted antiretroviral therapy in the SMART study', AIDS, 21, pp. 1957 - 1963,
    Journal articles | 2007
    Wand HC; Calmy A; Carey DL; Samaras K; Carr AD; Law MG; Cooper DA; Emery S, 2007, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', AIDS, 21, pp. 2445 - 2453
    Journal articles | 2007
    Winston A; Mallon PW; Satchell C; MacRae K; Williams KM; Schutz M; Law MG; Cooper DA; Emery S, 2007, 'The safety, efficacy, and pharmacokinetic profile of a switch in antiretroviral therapy to saquinavir, ritonavir, and atazanavir alone for 48 weeks and a switch in the saquinavir formulation', Clinical Infectious Diseases, 44, pp. 1475 - 1483
    Journal articles | 2006
    De Rose R; Sullivan MT; Dale CJ; Kelleher AD; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent SJ, 2006, 'Dose-response relationship of DNA and recombinant fowlpox virus prime-boost HIV vaccines.', Human Vaccines, 2, pp. 134 - 136
    Journal articles | 2006
    Dwyer D; Workman C; Hales GP; Amin J; Cooper DA; Miller J; Emery S, 2006, 'Enfuvirtide in HIV-1-infected individuals changing therapy to a nucleoside reverse transcriptase inhibitor sparing regimen: The ALLIANCE Study', Antiviral Therapy, 11, pp. 409 - 419
    Journal articles | 2006
    El-Sadr W; Lundgren JD; Neaton JD; Gordin F; Abrams D; Arduino R; Babiker AG; Burman W; Clumeck N; Cohen C; Cohn D; Cooper DA; Darbyshire JH; Emery S; Fatkenheuer G; Gazzard B; Hoy JF; Klingman K; Losso MH; Markowitz N; Neuhaus J; Phillips A; Rappaport C, 2006, 'CD4+ count-guided interruption of antiretroviral treatment.', New England Journal of Medicine, 355, pp. 2283 - 2296
    Journal articles | 2006
    Emery S; Dwyer DE; McKinnon M, 2006, 'Epilogue: Preparing for an influenza pandernic in Australia', Medical Journal of Australia, 185, pp. S80 - S80
    Journal articles | 2006
    Hales GP; Birch C; Crowe S; Workman C; Hoy JF; Kelleher AD; Lincoln D; Lincoln D; Law MG; Emery S, 2006, 'A randomised trial comparing genotypic and virtual phenotypic interpretation of HIV drug resistance: The CREST study.', PLoS Clinical Trials, 1, pp. e18
    Journal articles | 2006
    Harrod ME; Emery S; Dwyer DE, 2006, 'Antivirals in the management of an influenza pandemic', Medical Journal of Australia, 185, pp. S58 - S61
    Journal articles | 2006
    Kelleher AD; Puls R; Bebbington M; Boyle D; Kent S; Kippax SC; Purcell D; Thomson S; Wand HC; Cooper DA; Emery S; Ffrench RA, 2006, 'A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1', AIDS, 20, pp. 294 - 297
    Journal articles | 2006
    Lifson A; Rhame F; Belloso WH; Dragsted U; El-Sadr W; Gatell J; Hoy JF; Krum E; Nelson R; Pedersen C; Pett SL; Davey R, 2006, 'Reporting and evaluation of HIV-related clinical endpoints in two multicenter international clinical trials', HIV Clinical Trials, 7, pp. 125 - 141
    Journal articles | 2006
    McClelland RS; Baeten JM; Richardson BA; Lavreys L; Emery S; Mandaliya K; Ndinya-Achola JO; Overbaugh J, 2006, 'A comparison of genital HIV-1 shedding and sexual risk behavior among Kenyan women based on eligibility for initiation of HAART according to WHO guidelines', JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 41, pp. 611 - 615,
    Journal articles | 2006
    Mocroft A; Neaton JD; Bebchuk JD; Staszewski S; Antunes F; Knysz B; Law MG; Phillips AN; Lundgren JD, 2006, 'The feasibility of clinical endpoint trials in HIV infection in the highly active antiretroviral treatment (HAART) era', CLINICAL TRIALS, 3, pp. 119 - 132
    Journal articles | 2006
    Pace C; Grady C; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Forster HP; Killen J; Emanuel EJ, 2006, 'Post-trial access to tested interventions: The views of IRB/REC chair, investigators, and research participants in a multinational HIV/AIDS study', AIDS RESEARCH AND HUMAN RETROVIRUSES, 22, pp. 837 - 841,
    Journal articles | 2006
    Pett SL; Wand HC; Law MG; Arduino R; Lopez JC; Knysz B; Pereira L; Pollack S; Reiss P; Tambussi G, 2006, 'Evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial (ESPRIT): Geographical and gender differences in the baseline characteristics of participants', HIV Clinical Trials, 7, pp. 70 - 85
    Journal articles | 2006
    Puls R; Emery S, 2006, 'Therapeutic vaccination against HIV: current progress and future possibilities', Clinical Science, 110, pp. 59 - 71
    Journal articles | 2006
    Samaras K; Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2006, 'Dietary intake in HIV-infected men with lipodystrophy: relationships with body composition and metabolic parameters', Antiviral Therapy, 11, pp. L23 - L24,
    Journal articles | 2006
    Winston A; Amin J; Hales GP; Cooper DA; Emery S, 2006, 'Nonnucleoside reverse transcriptase inhibitor fold change or plasma concentration as a predictor of virological response over 48 weeks in highly treatment experienced HIV-positive individuals', AIDS Research and Human Retroviruses, 22, pp. 338 - 341
    Journal articles | 2006
    Winston A; Amin J; Marriott D; Mallon PW; Carr AD; Cooper DA; Emery S, 2006, 'Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy', HIV Medicine, 7, pp. 105 - 111
    Journal articles | 2006
    Yeni PG; Cooper DA; Aboulker J; Babiker AG; Carey DL; Darbyshire JH; Floridia M; Girard P; Goodall R; Hooker M; Mijch AM; Meiffredy V; Salzberger B, 2006, 'Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial.', Lancet, 368, pp. 287 - 298,
    Journal articles | 2006
    Youle M; Emery S; Fisher M; Nelson M; Fosdick L; Janossy G; Loveday C; Sullivan AM; Herzmann C; Wand HC; Davey Jr R; Johnson MA; Tavel JA; Lane HC; Sullaphen J, 2006, 'A randomised trial of subcutaneous intermittent interleukin-2 without antiretroviral therapy in HIV-infected patients: The UK-Vanguard study.', PLoS Clinical Trials, 1, pp. e3 - e3,
    Journal articles | 2005
    Carey DL; Wand HC; Martin A; Rothwell S; Emery S; Cooper DA; Carr AD, 2005, 'Evaluation of ultrasound for assessing facial lipoatrophy in a randomized, placebo-controlled trial', AIDS, 19, pp. 1325 - 1327
    Journal articles | 2005
    Duncombe CJ; Kerr SJ; Ruxrungtham K; Dore GJ; Law MG; Emery S; Lange J; Phanuphak P; Cooper DA, 2005, 'HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting', AIDS, 19, pp. 169 - 178
    Journal articles | 2005
    Emery S; Workman C; Puls R; Bloch M; Baker D; Bodsworth NJ; Anderson JA; Crowe SM; Hoy JF; Aichelburg A; Ward LA; Boyle D; Law MG; Kelleher AD; Cooper DA, 2005, 'Randomised, Placebo-Controlled, Phase 1/2a Evaluation of the Safety and Immunogenicity of Fowlpox Virus Expressing HIV gag-pol and Interferon-y in HIV-1 Infected Subjects', Human Vaccines, 1, pp. 232 - 238,
    Journal articles | 2005
    Emery SB; Hubbley JL; Darling MA; Roy D, 2005, 'Chemical factors for chemical-mechanical and electrochemical-mechanical planarization of silver examined using potentiodynamic and impedance measurements', MATERIALS CHEMISTRY AND PHYSICS, 89, pp. 345 - 353,
    Journal articles | 2005
    Kovacic JC; Martin A; Carey DL; Wand HC; Mallon PW; Feneley MP; Emery S; Cooper DA; Carr AD, 2005, 'Influence of rosiglitazone on flow-mediated dilation and other markers of cardiovascular risk in HIV-infected patients with lipoatrophy', Antiviral Therapy, 10, pp. 135 - 143
    Journal articles | 2005
    Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2005, 'In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA', Journal of Infectious Diseases, 191, pp. 1686 - 1696
    Journal articles | 2005
    Mallon PW; Wand HC; Law MG; Miller J; Cooper DA; Carr AD, 2005, 'Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia.', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 38, pp. 156 - 162,
    Journal articles | 2005
    Pace C; Emanuel EJ; Chuenyam T; Duncombe C; Bebchuk JD; Wendler D; Tavel JA; McNay LA; Phanuphak P; Forster HP; Grady C, 2005, 'The quality of informed consent in a clinical research study in Thailand.', IRB, 27, pp. 9 - 17,
    Journal articles | 2005
    Sabik L; Pace CA; Forster-Gertner HP; Wendler D; Bebchuk JD; Tavel JA; McNay LA; Killen J; Emanuel EJ; Grady C, 2005, 'Informed consent: Practices and views of investigators in a multinational clinical trial', IRB Ethics and Human Research, 27, pp. 13 - 18,
    Journal articles | 2005
    Wand HC; Law MG; Emery S; Cooper DA; Carr AD, 2005, 'Increase in limb fat after nucleoside analogue cessation is not associated with decreased visceral fat and has different risk factors', Antiviral Therapy, 10, pp. L5 - L5,
    Journal articles | 2005
    Winston A; Bloch MT; Carr AD; Amin J; Mallon PW; Ray J; Marriott D; Cooper DA; Emery S, 2005, 'Atazanavir trough plasma concentration monitoring in a cohort of HIV-1-positive individuals receiving highly active antiretroviral therapy', Journal of Antimicrobial Chemotherapy, 56, pp. 380 - 387
    Journal articles | 2005
    Winston A; Hales GP; Amin J; van Schaick E; Cooper DA; Emery S, 2005, 'The normalized inhibitory quotient of boosted protease inhibitors is predictive of viral load response in treatment-experienced HIV-1-infected individuals', AIDS, 19, pp. 1393 - 1399
    Journal articles | 2005
    Winters B; Harrigan R; Montaner JS; Perez-Elias M; Miller M; Emery S; van Leth F; Robinson P; Baxter J; Gazzard B; Pozniak A; Castor D; Hammer S; Rinehart A; Bacheler L, 2005, 'Clinically relevant breakpoints for virco (R) TYPE HIV-1 phenotypic resistance information', Antiviral Therapy, 10, pp. S39 - S39,
    Journal articles | 2004
    Arduino R; Nannini E; Rodriguez-Barradas M; Schrader S; Losso MH; Ruxrungtham K; Allende MC; Emery S; Fosdick L; Neaton JD; Tavel JA; Davey R; Lane HC, 2004, 'CD4 cell response to 3 doses of subcutaneous interleukin 2:Meta-analysis of 3 Vanguard studies', Clinical Infectious Diseases, 39, pp. 115 - 122
    Journal articles | 2004
    Carey DL; Workman C; Rogers GJ; Baker DA; Martin A; Wand HC; Emery S; Cooper DA; Carr AD, 2004, 'Rosiglitazone for HIV lipoatrophy: 84 weeks follow-up', Antiviral Therapy, 9, pp. L46 - L46,
    Journal articles | 2004
    Carr AD; Workman C; Carey DL; Rogers GJ; Martin A; Baker DA; Wand HC; Law MG; Samaras K; Emery S; Cooper DA, 2004, 'No effect of rosiglitazone for treatment of HIV-1 lipoatrophy:randomised, double-blind, placebo-controlled trial', Lancet, 363, pp. 429 - 438,
    Journal articles | 2004
    Dale C; De Rose R; Wilson K; Croom H; Thomson S; Coupar B; Ramsay AJ; Purcell D; Ffrench R; Law MG; Emery S; Cooper DA; Ramshaw I; Boyle D; Kent S, 2004, 'Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN[gamma] or IL-12', Vaccine, 23, pp. 188 - 197,
    Journal articles | 2004
    Mallon PW; Sedwell R; Unemori P; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'Changes in nuclear gene expression resulting from NRTI-induced inhibition of mitochondrial transcription reveal links between mitochondrial dysfunction and lipid metabolism', Antiviral Therapy, 9, pp. L56 - L56,
    Journal articles | 2004
    Mallon PW; Unemori P; Sedwell R; Morey AL; Rafferty M; Williams KM; Chisholm DJ; Samaras K; Emery S; Kelleher AD; Cooper DA; Carr AD, 2004, 'In vivo nucleoside reverse transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes independent to HIV infection', Antiviral Therapy, 9, pp. L11 - L11,
    Journal articles | 2004
    Martin A; Smith DE; Carr AD; Ringland C; Amin J; Emery S; Hoy JF; Workman C; Doong N; Freund J; Cooper DA, 2004, 'Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study', AIDS, 18, pp. 1029 - 1036,
    Journal articles | 2004
    McClelland RS; Baeten JM; Overbaugh J; Richardson BA; Mandaliya K; Emery S; Lavreys L; Ndinya-Achola JO; Bankson DD; Bwayo JJ; Kreiss JK, 2004, 'Micronutrient supplementation increases genital tract shedding of HIV-1 in women - Results of a randomized trial', JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 37, pp. 1657 - 1663,
    Journal articles | 2004
    Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98
    Journal articles | 2004
    Ungsedhapand C; Srasuebkul P; Cardiello P; Ruxrungtham K; Ratanasuwan W; Kroon E; Tongtalung M; Juengprasert N; Ubolyam S; Siangphoe U; Emery S; Lange JM; Cooper DA; Phanuphak P, 2004, 'Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a Thai population with HIV infection', JAIDS: Journal of Acquired Immune Deficiency Syndromes, 36, pp. 693 - 701
    Journal articles | 2003
    Amin J; Moore A; Carr A; French MA; Law M; Emery S; Cooper DA, 2003, 'Combined Analysis of Two-Year Follow-Up from Two Open-Label Randomized Trials Comparing Efficacy of Three Nucleoside Reverse Transcriptase Inhibitor Backbones for Previously Untreated HIV-1 Infection: OzCombo 1 and 2', HIV Research & Clinical Practice, 4, pp. 252 - 261,
    Journal articles | 2003
    Amin J; Moore A; Carr AD; French MA; Law MG; Emery S; Cooper DA, 2003, 'Combined analysis of two-year follow-up from two open-label randomized trials comparing efficacy of three nucleoside reverse transcriptase inhibitor backbones for previously untreated HIV-1 infection: OzCombo 1 and 2', HIV Clinical Trials, 4, pp. 252 - 261
    Journal articles | 2003
    Birch C; Middleton T; Hales GP; Cooper DA; Law MG; Crowe S; Hoy JF; Emery S, 2003, 'Limited evolution of HIV antiretroviral drug resistance-associated mutations during the performance of drug resistance testing', Journal of Acquired Immune Deficiency Syndrome, 32, pp. 57 - 61
    Journal articles | 2003
    Carr AD; Emery S; Law MG; Puls R; Lundgren JD; Powderly W, 2003, 'An objective case definition of lipodystrophy in HIV-infected adults: a case-control study', Lancet, 361, pp. 726 - 735
    Journal articles | 2003
    Carr AD; Law MG, 2003, 'An objective lipodystrophy severity grading scale using the lipodystrophy case definition score', Journal of Acquired Immune Deficiency Syndrome, 33, pp. 571 - 576,
    Journal articles | 2003
    Clegg AO; Williamson P; Biti RA; Cooper DA; Emery S; Carr AD; Stewart GJ, 2003, 'Chemokine receptor genotype and response to interleukin-2 therapy in HIB-1-infected individuals', Clinical Immunology, 106, pp. 36 - 40
    Journal articles | 2003
    Ioannidis JP; Trikalinos TA; Law MG; Carr AD, 2003, 'HIV lipodystrophy case definition using artificial neural network modelling.', Antiviral Therapy, 8, pp. 435 - 441
    Journal articles | 2003
    Law MG; Emery S, 2003, 'Selective exclusion of treatment arms in multi-arm randomized clinical trials', Statistics in Medicine, 22, pp. 19 - 30
    Journal articles | 2003
    Miller J; Carr AD; Emery S; Law MG; Mallal SS; Baker D; Smith DG; Kaldor JM; Cooper DA, 2003, 'HIV lipodystrophy: prevalence, severity and correlates of risk in Australia', HIV Medicine, 4, pp. 293 - 301
    Journal articles | 2003
    Sayer DC; Land S; Gizzarelli L; French M; Hales G; Emery S; Christiansen FT; Dax EM; Dunne M; Crowe S; Birch C; Middleton T; Saksena N; Bryson G; Salem H; Cunningham P; Suzuki K; Schroeder B; Rawlings L; Higgins G; Chuah J; Roth N; Barnes T; Mills G; Daye J; Watson J, 2003, 'Quality assessment program for genotypic antiretroviral testing improves detection of drug resistance mutations', Journal of Clinical Microbiology, 41, pp. 227 - 236,
    Journal articles | 2003
    Sirivichayakul S; Ruxrungtham K; Ungsedhapand C; Techasathit W; Ubolyam S; Chuenyam T; Emery S; Cooper D; Lange J; Phanuphak P, 2003, 'Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors', AIDS, 17, pp. 1889 - 1896,
    Journal articles | 2002
    Emery S; Abrams D; Cooper DA; Darbyshire JH; Lane HC; Lundgren JD; Neaton JD, 2002, 'The evaluation of subcutaneous proleukin® (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT. Control Clin Trials', Control Clin Trials, 23, pp. 198 - 220
    Journal articles | 2002
    Emery S; Birch C; Crowe S; Hoy J; Workman C; Kelleher T; McKenna P; Cooper D; Lincoln D; Hales G; Law M, 2002, 'CREST - A randomised comparison of two resistance test platforms: genotype and genotype plus VirtualPhenotype (TM): interim results', ANTIVIRAL THERAPY, 7, pp. S152 - S152,
    Journal articles | 2002
    Emery S; Cooper DA, 2002, 'HIV medicine', Medical Journal of Australia, 176, pp. 21 - 21
    Journal articles | 2002
    French M; Amin J; Roth N; Carr A; Law M; Emery S; Drummond F; Cooper D; investigators* OBOO2, 2002, 'Randomized, open-Label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: The OzCombo 2 study', HIV Research & Clinical Practice, 3, pp. 177 - 185,
    Journal articles | 2002
    French MA; Amin J; Roth N; Law MG; Emery S; Drummond F, 2002, 'Randomized, open-label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 infection: The OzCombo 2 Study', HIV Clinical Trials, 3, pp. 177 - 185
    Journal articles | 2002
    McNay LA; Tavel JA; Oseekey K; McDermott CM; Mollerup D; Bebchuk JD, 2002, 'Regulatory approvals in a large multinational clinical trial: the ESPRIT experience', CONTROLLED CLINICAL TRIALS, 23, pp. 59 - 66,
    Journal articles | 2002
    Panteleeff DD; Emery S; Richardson BA; Rousseau C; Benki S; Bodrug S; Kreiss JK; Overbaugh J, 2002, 'Validation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay with genital swabs and breast milk samples', JOURNAL OF CLINICAL MICROBIOLOGY, 40, pp. 3929 - 3937,
    Journal articles | 2001
    Babiker AG; Darbyshire JH; Cooper DA; Hooker MH; Withnall R; Yeni P; Angarano G; Antunes F; Churchill D; Conway B; Flepp M; Lelekis M; Gatell J; Girard PM; Hemmer R; Lundgren J; Mijch A; Mulcahy F; Ristola M; Salzberger B; Sandström E; Staszewski S; Weber J; De Wit S; Aboulker JP; Emery S; Floridia M; Gartland M; Manion D; Popescu M; Schnittman S; Stek M; Verbiest W; Flandre P; Law M; Schade-Brittinger C; Walker S; Bucciardini R; Boukli N; Carey D; Gargalianos P; Mollerup D; Brun-Vezinet F; Loveday C; Seligmann M, 2001, 'An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methods of the initio trial', Controlled Clinical Trials, 22, pp. 160 - 175,
    Journal articles | 2001
    Emery S; Lane HC; Neaton JD, 2001, 'Interleukin-2 in clinical trials: Other factors to be considered - Reply', JOURNAL OF INFECTIOUS DISEASES, 183, pp. 680 - 680,
    Journal articles | 2001
    Nannini EC, 2001, 'Interleukin-2 in clinical trials: Other factors to be considered (multiple letters)', Journal of Infectious Diseases, 183, pp. 679 - 680,
    Journal articles | 2001
    Pett SL; Emery S, 2001, 'Immunomodulators as adjunctive therapy for HIV-1 infection', Journal of Clinical Virology, 22, pp. 289 - 295,
    Journal articles | 2001
    Tavel JA; Fosdick L, 2001, 'Closeout of four phase II Vanguard trials and patient rollover into a large international phase III HIV clinical endpoint trial', Controlled Clinical Trials, 22, pp. 42 - 48,
    Journal articles | 2000
    Carr AD; Chuah J; Hudson J; French MA; Hoy JF; Law MG; Sayer D; Emery S; Cooper DA; On BOTC, 2000, 'A randomised, open-label comparison of three highly active antiretroviral therapy regimes including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study', AIDS, 14, pp. 1171 - 1180
    Journal articles | 2000
    Clezy KR; Emery S, 2000, 'Clinical trials of antiretroviral therapy in developing countries', Australian and New Zealand Journal of Medicine, 30, pp. 3 - 4,
    Journal articles | 2000
    Emery S; Bodrug S; Richardson BA; Giachetti C; Bott MA; Panteleeff D; Jagodzinski LL; Michael NL; Nduati R; Bwayo J; Kreiss JK; Overbaugh J, 2000, 'Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya', JOURNAL OF CLINICAL MICROBIOLOGY, 38, pp. 2688 - 2695,
    Journal articles | 2000
    Emery S; Capra WB; Cooper DA; Mitsuyasu RT; Kovacs JA; Vig P; Smolskis M; Saravolatz LD; Lane HC; Fyfe G; Curtin PT; For TII, 2000, 'Pooled analysis of 3 randomized, controlled trials of interleukin-2 therapy in adult human immunodeficiency virus type 1 disease', Journal of Infectious Diseases, 182, pp. 428 - 434
    Journal articles | 2000
    Losso MH; Belloso WH; Emery S; Benetucci JA; Cahn PE; Lasala MC; Lopardo G; Salomon H; Saracco M; Nelson E; Law MG; Davey RC; Allende MC; Lane HC; And TVSG, 2000, 'A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts ? 350/mm³', Journal of Infectious Diseases, 181, pp. 1614 - 1621
    Journal articles | 2000
    Losso MH; Belloso WH; Emery S, 2000, 'A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4(+) cell counts >= 350/mm(3) (vol 181, pg 1614, 2000)', JOURNAL OF INFECTIOUS DISEASES, 181, pp. 2122 - 2122,
    Journal articles | 2000
    Losso MH; Belloso WH; Emery S, 2000, 'Erratum: A randomized, controlled, phase II trial comparing escalating doses of subcutaneous interleukin-2 plus antiretrovirals versus antiretrovirals alone in human immunodeficiency virus-infected patients with CD4+ cell counts ≥350/mm3 (Journal of Infectious Diseases (May 2000) 181 (1614-1621))', Journal of Infectious Diseases, 181, pp. 2122,
    Journal articles | 2000
    Mills J; Carr AD; Smith DE; Emery S; Law MG; Grey PA; Cooper DA, 2000, 'Lipodystrophy following antiretroviral therapy of primary HIV infection (letter)', AIDS, 14, pp. 2406 - 2407
    Journal articles | 2000
    Ruxrungtham K; Suwanagool S; Tavel JA; Chuenyam M; Kroon E; Ubolyam S; Buranapraditkun S; Techasathit W; Li Y; Emery S; Davey RC; Fosdick L; Kunanusont C; Lane HC; Phanuphak P; And TVSG, 2000, 'A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand', AIDS, 14, pp. 2509 - 2513
    Journal articles | 1999
    Cooper DA; Emery S, 1999, 'Latent reservoirs of HIV infection: Flushing with IL-2?', Nature Medicine, pp. 611 - 612
    Journal articles | 1998
    Carr AD; Emery S; Lloyd AR; Hoy JF; Garsia R; French MA; Stewart GA; Fyfe G; Cooper DA, 1998, 'Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, milticenter study', Journal of Infectious Diseases, 178, pp. 992 - 999,
    Journal articles | 1998
    Cooper DA; Emery S, 1998, 'Therapeutic strategies for HIV infection - time to think hard. (Editorial)', New England Journal of Medicine, pp. 1319 - 1321
    Journal articles | 1998
    Kelleher AD; Roggensack M; Emery S; Carr AD; French MA; Cooper DA, 1998, 'Effects of IL-2 therapy in asymptomatic HIV-infected individuals on proliferative responses to mitogens, recall antigens and HIV-related antigens', Clinical and Experimental Immunology, 113, pp. 85 - 91
    Journal articles | 1997
    Emery S; Cooper DA, 1997, 'Drug companies have a duty to continue treatment', British Medical Journal: Clinical Research, pp. 889 - 889
    Journal articles | 1997
    Emery S; Lane HC, 1997, 'Immune reconstitution in HIV infection', Current Opinion in Immunology, 9, pp. 568 - 572,
    Journal articles | 1997
    Kelleher S; Emery S; Cunningham PH; Duncombe CJ; Carr AD; Golding H; Forde S; Hudson J; Roggensack M; Forrest BD; Cooper DA, 1997, 'Safety and immunogenicity of UBI HIV-1MN octameric V3 peptide vaccine administered by subcutaneous injection', AIDS Research and Human Retroviruses, 13, pp. 29 - 32
    Journal articles | 1996
    Carr AD; Emery S; Kelleher AD; Law MG; Cooper DA, 1996, 'CD8+ lymphocyte responses to antiretroviral therapy of HIV infection', Journal of acquired immune deficiency syndrome and human retrovirology, 13, pp. 320 - 326
    Journal articles | 1996
    Dax EM; Best SJ, 1996, 'If it's the virus why aren't we measuring it? [3]', Medical Journal of Australia, 165, pp. 119,
    Journal articles | 1996
    Emery S; Lane HC, 1996, 'Immune-based therapies in HIV infection', AIDS, 10, pp. S159 - 164,
    Journal articles | 1996
    Emery S; Lane HC, 1996, 'Immune-based therapies in HIV infection: recent developments.', AIDS (London, England), 10 Suppl A,
    Journal articles | 1996
    Schooley RT; Ramirez-Ronda C; Lange JM; Cooper DA; Lavelle J; Lefkowitz L; Moore MW; Larder BA; St Clair M; Mulder JW; Mckinnis R; Pennington KN; Harrigan PR; Kinghorn I; Steel H; Rooney J, 1996, 'Virologic and immunologic benefits of initial combination therapy with zidovudine and zalcitabine or didanosine compared with zidovudine monotherapy', Journal of Infectious Diseases, 173, pp. 1354 - 1366,
    Journal articles | 1995
    Emery S; Carr A; Cooper DA, 1995, 'If it's the virus, why aren't we measuring it?', The Medical journal of Australia, 163, pp. 508 - 509,
    Journal articles | 1995
    Emery S; Cooper DA, 1995, 'Antiretro viral therapy of human immunodeficiency virus type‐1 (HIV‐1) infection', Australian and New Zealand Journal of Medicine, 25, pp. 344 - 349,
    Journal articles | 1993
    Cooper DA; Gatell JM; Kroon S; Clumeck N; Millard J; Goebel FD; Bruun JN; Stingl G; Melville RL; Gonzalez-Lahoz J; Stevens JW; Fiddian AP, 1993, 'Zidovudine in Persons with Asymptomatic HIV Infection and CD4+ Cell Counts Greater than 400 per Cubic Millimeter', New England Journal of Medicine, 329, pp. 297 - 303,
    Journal articles | 1990
    Slater TF; Cheeseman KH; Benedetto C; Collins M; Emery S; Maddix SP; Nodes JT; Proudfoot K; Burton GW; Ingold KU, 1990, 'Studies on the hyperplasia ('regeneration') of the rat liver following partial hepatectomy. Changes in lipid peroxidation and general biochemical aspects', Biochemical Journal, 265, pp. 51 - 59,
    Journal articles | 1988
    Cheeseman KH; Emery S; Maddix SP; Slater TF; Burton GW; Ingold KU, 1988, 'Studies on lipid peroxidation in normal and tumour tissues. The Yoshida rat liver tumour', Biochemical Journal, 250, pp. 247 - 252,
    Journal articles | 1987
    Cheeseman KH; Davies MJ; Emery S; Maddix SP; Slater TF, 1987, 'Effects of αtocopherol on carbon tetrachloride metabolism in rat liver microsomes', Free Radical Research, 3, pp. 325 - 330,
    Journal articles | 1985
    Emery S; Oldham HG; Norman SJ; Chenery RJ, 1985, 'The effect of cimetidine and ranitidine on paracetamol glucuronidation and sulphation in cultured rat hepatocytes', Biochemical Pharmacology, 34, pp. 1415 - 1421,
  • Conference Abstracts | 2019
    Polizzotto M; Van Bockel D; Law C; Roberts J; Buckland G; Just S; Comben S; Hillman R; Gilson R; Pett S; Poynten M; Law M; Kelleher A; Emery S, 2019, 'Clearance of HPV anal premalignant lesions and modulation of systemic immune responses to HPV oncogenes with low dose pomalidomide', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SWITZERLAND, Geneva, Vol. 30, presented at Immuno-Oncology Congress of the European-Society-for-Medical-Oncology (ESMO), SWITZERLAND, Geneva, 11 December 2019 - 14 December 2019,
    Conference Papers | 2018
    Kunisaki KM; Niewoehner DE; Collins G; Aagaard B; Atako NB; Bakowska E; Clarke A; Corbelli GM; Ekong E; Emery S; Finley EB; Florence E; Infante RM; Kityo CM; Madero JS; Nixon DE; Tedaldi E; Vestbo J; Wood R; Connett JE, 2018, 'Pulmonary Effects of Immediate Versus Deferred Antriretroviral Treatment Initiation: Final Follow-Up Results from the Randomized Strategic Timing of Antiretroviral Treatment (START) Pulmonary Substudy', in AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, AMER THORACIC SOC, CA, San Diego, presented at International Conference of the American-Thoracic-Society, CA, San Diego, 18 May 2018 - 23 May 2018,
    Preprints | 2017
    Jacobsen H; Holm SL; Lacatusu M-E; Rømer AT; Bertelsen M; Boehm M; Toft-Petersen R; Grivel J-C; Emery SB; Udby L; Wells BO; Lefmann K, 2017, Distinct nature of static and dynamic magnetic stripes in cuprate superconductors, ,
    Conference Papers | 2016
    Belonohy E; Baker A; Balshaw N; Bernardo J; Blatchford P; Camp P; Cane J; Ciric D; Craven R; Emery S; Felton R; Gee S; Graham B; Haupt T; Hotchin S; Jones G; Keeling D; Jones T; Keenan T; Knipe S; McAdams R; Rimini F; Sips A; Warren R; Zastrow K-D, 2016, 'Technical rehearsal of tritium operation at JET', in FUSION ENGINEERING AND DESIGN, ELSEVIER SCIENCE SA, CZECH REPUBLIC, Prague, pp. 196 - 200, presented at 29th Symposium on Fusion Technology (SOFT), CZECH REPUBLIC, Prague, 05 September 2016 - 09 September 2016,
    Conference Papers | 2016
    Madhavi V; Wines B; Emery S; Amin J; Kelleher A; Hogarth M; Stratov I; Kent S, 2016, '"HIV-1 controllers" - what's their secret?', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 74 - 74, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016,
    Conference Papers | 2016
    Rodger A; Lampe F; Burman W; Gruhlich A; Friedland G; El-Sadr W; Neaton J; Emery S; Corbelli G; Molina JM; Orkin C; Gatell J; Gerstoft J; Ruxrungtham K; de Souza MB; Phillips A, 2016, 'Assessment of the impact of early ART on sexual behaviour in INSIGHT strategic timing of antiretroviral treatment (START) trial', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD,
    Conference Papers | 2016
    Wines BD; Vanderven HA; Esparon S; Madhavi V; Center RJ; Kristensen AB; Gonelli CA; Poumbourios A; Parsons M; Emery S; Kelleher A; Purcell DFJ; Kent SJ; Hogarth PM, 2016, 'Fc gamma R ectodomain probes measure anti-viral IgG effector function', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 1256 - 1257, presented at International Congress of Immunology (ICI), AUSTRALIA, Melbourne, 21 August 2016 - 26 August 2016,
    Conference Papers | 2015
    Achhra AC; Phillips AN; Emery S; MacArthur RD; Furrer H; De Wit S; Losso MH; Law MG, 2015, 'PRE-THERAPY INFLAMMATION/COAGULATION ACTIVATION AND LONG-TERM CD4 RESPONSE TO ANTIRETROVIRAL THERAPY', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A73 - A73,
    Conference Abstracts | 2015
    Bunupuradah T; Kiertiburanakul S; Avihingsanon A; Chetchotisakd P; Techapornroong M; Leerattanapetch N; Kantipong P; Bowonwatanuwong C; Banchongkit S; Klinbuayaem V; Mekviwattanawan S; Nimitvilai S; Jirajariyavej S; Prasithsirikul W; Munsakul W; Bhakeecheep S; Chaivooth S; Phanuphak P; Cooper DA; Apornpong T; Kerr SJ; Emery S; Ruxrungtham K, 2015, 'Atazanavir/ritonavir 200/100 mg is non-inferior to atazanavir/ritonavir 300/100 mg in virologic suppressed HIV-infected Thai adults: a multicentre, randomized, open-label trial: LASA', in JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, JOHN WILEY & SONS LTD, Vol. 18,
    Conference Papers | 2013
    Emery S; Leigh S, 2013, 'How occupational therapy can enhance an improving access to psychological therapy service', in BRITISH JOURNAL OF OCCUPATIONAL THERAPY, SAGE PUBLICATIONS LTD, pp. 84 - 84,
    Conference Papers | 2013
    Land S; Tu E; Swenson L; Kelleher A; Kaye S; Pett SL; Emery S; Kaiser R; Silk D; Berthon-Jones N; Harrigan PR, 2013, 'Proviral DNA testing of HIV tropism in the Maraviroc Switch Collaborative Study (MARCH) - results of a three-phase quality assurance (QA) programme', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A144 - A144, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CANADA, Toronto, 04 June 2013 - 08 June 2013,
    Conference Papers | 2013
    Larder BA; Revell AD; Wang D; Hamers R; Tempelman H; Barth R; Wensing AMJ; Morrow C; Wood R; van Sighem A; Reiss P; Nelson M; Emery S; Montaner JM; Lane HC, 2013, 'Accurate prediction of response to HIV therapy without a genotype: a potential tool for therapy optimization in resource-limited settings', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Toronto, pp. A20 - A20, presented at International Workshop on HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CANADA, Toronto, 04 June 2013 - 08 June 2013,
    Reports | 2013
    Tu E; Swenson LC; Land S; Pett S; Emery S; Marks K; Kelleher AD; Kaye S; Kaiser R; Schuelter E; Harrigan R, 2013, Reply to "issues on results of the external quality assessment for proviral DNA testing of HIV-1 tropism in the maraviroc switch collaborative study",
    Conference Abstracts | 2012
    Danta M; Zaunders J; Bailey MR; Marks K; Seddiki N; Emery S; Murray JM; Cooper DA; Koelsch K; Kelleher AD, 2012, 'Primary HIV-1 infection (PHI) is associated with reduced CD4 cell counts in terminal ileum biopsies, but not other gut biopsy sites', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL, Vol. 27, pp. 19 - 19,
    Conference Papers | 2011
    Ebeling PR; Haskelberg H; Hoy J; Amin J; Emery S; Carr A, 2011, 'LOWER FAT MASS AND LOWER BONE FORMATION PREDICT GREATER BONE LOSS WITH TENOFOVIR IN HIV-INFECTED ADULTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Gold Coast, pp. S614 - S615, presented at IOF Regionals 2nd Asia-Pacific Osteoporosis and Bone Meeting / ANZBMS Annual Scientific Meeting held with the JSBMR, AUSTRALIA, Gold Coast, 04 September 2011 - 08 September 2011,
    Conference Papers | 2010
    Bloch M; Martin A; Amin I; Emery S; Carr A; Baker D; Cooper DA, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010,
    Conference Papers | 2010
    Bloch M; Martin A; Amin J; Emery S; Carr A; Baker D; Cooper DA, 2010, 'Predictors of limb fat changes in patients switched to tenofovir-emtricitabine or abacavir-lamivudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, ENGLAND, London, pp. A7 - A7, presented at 12th International Workshop on Adverse Drug Reactions and Co-Morbidities in HIV, ENGLAND, London, 04 November 2010 - 06 November 2010,
    Preprints | 2010
    Emery SB; Cheng C-J; Kan D; Rueckert FJ; Alpay SP; Nagarajan V; Takeuchi I; Wells BO, 2010, Phase Coexistence Near a Morphotropic Phase Boundary in Sm-doped BiFeO3 Films,
    Conference Papers | 2010
    Larder BA; Wang D; Revell AD; Emery S; De Wolf F; Nelson M; Perez Elias MJ; Harrigan PR; Montaner JS, 2010, 'The development of computational models that accurately predict virological response to HIV therapy to power an online treatment selection tool', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CROATIA, Dubrovnik, pp. A89 - A89, presented at Workshop on International HIV and Hepatitis Virus Drug Resistance and Curative Strategies, CROATIA, Dubrovnik, 08 July 2010 - 12 July 2010,
    Conference Papers | 2010
    Larder BA; Wang D; Revell AD; Emery S; De Wolf F; Nelson M; Perez Elias MJ; Harrigan PR; Montaner JS, 2010, 'The development of computational models that accurately predict virological response to HIV therapy to power an online treatment selection tool', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, Dubrovnik, CROATIA, pp. A89 - A89, presented at International HIV and Hepatitis Virus Drug Resistance and Curative Strategies Workshop, Dubrovnik, CROATIA, 08 June 2010 - 12 June 2010,
    Conference Papers | 2009
    Carey D; Amin J; Emery S, 2009, 'Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir in randomized trials: systematic review and meta-analysis', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A58 - A58, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009,
    Conference Papers | 2009
    Puls RL; Srasuebkul P; Petoumenos K; Emery S; Cooper DA, 2009, 'Anthropometric and metabolic outcomes in a 48-week randomized, open-label study of three different combination antiretroviral regimens as initial therapy for HIV infection', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, PA, Philadelphia, pp. A8 - A9, presented at 11th International Workshop on AdverseDrug Reactions and Co-Morbidities in HIV, PA, Philadelphia, 26 October 2009 - 28 October 2009,
    Conference Papers | 2009
    Revell AD; Wang D; Harrigan R; Gatell J; Ruiz L; Emery S; Perez-Elias MJ; Torti C; Baxter J; DeWolf F; Gazzard B; Geretti AM; Staszewski S; Hamers R; Wensing AMJ; Lange J; Montaner JM; Larder BA, 2009, 'Computational models developed without a genotype for resource-poor countries predict response to HIV treatment with 82% accuracy', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, FL, Ft Myers, pp. A38 - A38, presented at 18th International HIV Drug Resistance Workshop, FL, Ft Myers, 09 June 2009 - 13 June 2009,
    Conference Papers | 2008
    Buchbinder SP; Mehrotra DV; Duerr A; Fitzgerald DW; Mogg R; Li D; Gilbert PB; Lama JR; Marmor M; del Rio C; McElrath MJ; Casimiro DR; Gottesdiener KM; Chodakewitz JA; Corey L; Robertson MN, 2008, 'Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial', in The Lancet, pp. 1881 - 1893,
    Conference Papers | 2006
    Samaras K; Wand H; Law M; Emery S; Cooper DA; Carr A, 2006, 'Metabolic syndrome in HIV-infected patients using IDF and ATPIII criteria: prevalence, discordance and clinical utility', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006,
    Conference Papers | 2006
    Wand H; Calmy A; Carey D; Samaras K; Carr A; Law M; Cooper D; Emery S, 2006, 'Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV-infected adults', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CA, San Francisco, pp. L4 - L4, presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CA, San Francisco, 24 September 2006 - 26 September 2006,
    Conference Papers | 2005
    Winters B; Harrigan R; Montaner J; Perez-Elias M; Millers M; Emery S; van Leth F; Robinson P; Baxter JD; Gazzard B; Pozniak A; Castor D; Hammer S; Rinehart A; Bacheler L, 2005, 'Clinically relevant breakpoints for virco (R) TYPE HIV-1 phenotypic resistance information', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CANADA, Quebec City, pp. S39 - S39, presented at 14th International HIV Drug Resistance Workshop, CANADA, Quebec City, 07 June 2005 - 11 June 2005,
    Conference Papers | 2004
    Bacheler LT; Winters B; Nauwelaers D; Rinehart A; McGregor M; Harrigan R; Perez-Elias M; Miller M; Emery S; van Leth F; Robinson P; Baxter JD; Pozniak A, 2004, 'Estimation of phenotypic clinical cutoffs for VirtualPhenotype (TM) through meta analyses of clinical trial and cohort data', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SPAIN, Tenerife, pp. U108 - U109, presented at 13th International HIV Drug Resistance Workshop, SPAIN, Tenerife, 08 June 2004 - 12 June 2004,
    Conference Papers | 2004
    Winters B; Bacheler LT; Nauwelaers D; Rinehart A; McGregor M; Harrigan R; Perez-Elias M; Miller M; Emery S; van Leth F; Hall D; Baxter JD; Pozniak A, 2004, 'Evaluation of different approaches for the definition of clinically relevant breakpoints for phenotypic resistance data', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, SPAIN, Tenerife, pp. U92 - U92, presented at 13th International HIV Drug Resistance Workshop, SPAIN, Tenerife, 08 June 2004 - 12 June 2004,
    Conference Papers | 2003
    Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'HIV Lipodystrophy Case Definition Study Group. Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. 57 - 57
    Conference Papers | 2003
    Puls R; Munier M; MCgHIE K; Chadborn I; Emery S; Kelleher AD; Law MG; Carr AD, 2003, 'Impact of adiponectin, C-reactive protein and leptin on the HIV lipodystrophy case definition', in Antiviral Therapy, Int Medical Press Ltd, pp. L73 - L73
    Conference Papers | 2002
    Amin J; Carr A; Hill A; Emery S; Law M; Cooper DA, 2002, 'Haematological changes in patients randomized to HAART regimens containing either zidovudine or stavudine', in ANTIVIRAL THERAPY, INT MEDICAL PRESS LTD, CALIFORNIA, SAN DIEGO, pp. L60 - L60, presented at 4th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, CALIFORNIA, SAN DIEGO, 22 September 2002 - 25 September 2002,
    Conference Papers | 1999
    Pantaleo G, 1999, 'Immune reconstitution in HIV infection', in AIDS RESEARCH AND HUMAN RETROVIRUSES, MARY ANN LIEBERT INC PUBL, pp. 1600 - 1600,
    Conference Papers | 1998
    Losso M; Belloso W; Benetucci J; Cahn P; Lasala MB; Lopardo G; Clara L; Allende M; Emery S; Davey R; Lane HC, 1998, 'A phase II study of subcutaneous (SC) IL-2 plus antiretrovirals (ARV) vs ARV alone in patients with HIV infection and CD4+ cell count >= 350/MM3.', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. S65 - S65,
    Conference Papers | 1991
    SLATER TF; CHEESEMAN KH; CARRIE ML; LI L; CLUTTON S; NIGAM S; EMERY S; INGOLD KU, 1991, 'DISTURBANCES OF LIPID-PEROXIDATION IN RAT-LIVER CANCER-CELLS AND IN NORMAL REGENERATING RAT-LIVER', in Nigam S; Honn KV; Marnett LJ; Walden TL (eds.), EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RADIATION-INJURY, KLUWER ACADEMIC PUBLISHERS, GERMANY, FREE UNIV BERLIN, UNIVESSITATSKLINIKUM STEGITZ, BERLIN, pp. 81 - 88, presented at 2ND INTERNATIONAL CONF ON EICOSANOIDS AND OTHER BIOACTIVE LIPIDS IN CANCER, INFLAMMATION AND RADIATION INJURY, GERMANY, FREE UNIV BERLIN, UNIVESSITATSKLINIKUM STEGITZ, BERLIN, 17 September 1991 - 21 September 1991,
    Conference Papers | 1988
    CHEESEMAN KH; EMERY S; MADDIX SP; PROUDFOOT K; BURTON GW; INGOLD KU; SLATER TF, 1988, 'LIPID-PEROXIDATION IN LIVER-TUMORS AND REGENERATING LIVER', in POLI G; CHEESEMAN KH; DIANZANI MU; SLATER TF (eds.), FREE RADICALS IN THE PATHOGENESIS OF LIVER INJURY, PERGAMON PRESS LTD, ITALY, TURIN, pp. 165 - 175, presented at 2ND CONGRESS ON FREE RADICALS IN LIVER INJURY, ITALY, TURIN, 09 June 1988 - 11 June 1988,